data_4c7q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4c7q _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.471 ' HG3' HG21 ' A' ' 53' ' ' THR . 12.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.477 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 ' HG1' ' HB2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.591 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.441 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 . . . . . 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HG3' HG23 ' A' ' 38' ' ' ILE . 40.0 mmt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.471 HG21 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.498 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 ' CG2' HD22 ' A' ' 13' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' HG11 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.478 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 HG11 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.625 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.573 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.458 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.573 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.625 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.512 ' SD ' HD12 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.243 0.727 0 CA-C-O 121.231 0.538 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.475 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.452 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 . . . . . 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.568 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.585 0.231 . . . . 0.0 111.178 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.503 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.51 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.51 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.515 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.431 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.493 ' CZ ' ' HG1' ' A' ' 53' ' ' THR . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.715 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 121.129 0.49 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.493 ' HG1' ' CZ ' ' A' ' 7' ' ' ARG . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.715 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.57 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.539 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.407 HD22 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.536 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.498 0.189 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HG3' ' OD2' ' A' ' 56' ' ' ASP . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.428 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.407 ' CG2' HD22 ' A' ' 13' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.431 -1.425 0 CA-C-O 121.236 0.541 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.55 ' HZ3' ' CG ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.51 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CD1' ' HE3' ' A' ' 60' ' ' MET . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.477 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.56 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.733 0.301 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HG3' HD22 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.422 ' HE3' ' CD1' ' A' ' 6' ' ' TYR . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.518 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 78' ' ' THR . 2.4 t-20 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 75' ' ' ARG . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.538 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.675 0 CA-C-O 120.808 0.337 . . . . 0.0 111.684 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.803 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.803 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 64' ' ' ILE . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.511 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HZ3' ' CG ' ' A' ' 56' ' ' ASP . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' CG ' ' HZ3' ' A' ' 55' ' ' LYS . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' MET . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.528 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.511 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 ' HG1' ' HB2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.542 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.483 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.542 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 CA-C-O 120.854 0.359 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.524 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.431 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.431 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.727 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.462 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.512 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.439 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.439 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 . . . . . 0 C--O 1.222 -0.376 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.51 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.577 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.253 1.261 0 CA-C-O 121.5 0.667 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.452 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.44 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.673 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' CG2' ' A' ' 77' ' ' ILE . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.417 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 HG23 HD13 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.673 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.402 ' CG2' HD22 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.57 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 34' ' ' ASP . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.776 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 HD12 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' THR . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 14.5 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' CG ' ' HG1' ' A' ' 53' ' ' THR . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 1.4 pm0 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.439 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' SG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 7.7 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.47 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HZ2' ' CD ' ' A' ' 5' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.491 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.47 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.406 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.47 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.457 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.727 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' HE2' ' A' ' 58' ' ' LYS . 28.1 ttt -176.26 -49.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.84 99.68 3.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 4.2 mm-40 -88.36 106.25 18.11 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.9 p -165.4 174.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.471 ' HG3' HG21 ' A' ' 53' ' ' THR . 12.0 tt0 -62.2 119.98 10.05 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.555 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.477 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 ' HG1' ' HB2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.591 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.441 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.61 164.14 12.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.58 108.64 21.38 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 47.6 mtm180 -71.39 -42.72 68.02 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.878 0.847 . . . . 0.0 108.759 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 3.2 mp0 -54.86 -46.05 74.65 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 113.026 -1.897 . . . . 0.0 113.279 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.8 p -110.4 -11.06 14.55 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.1 56.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.711 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -106.65 -164.81 1.02 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 t -97.06 162.93 13.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' HG3' HG23 ' A' ' 38' ' ' ILE . 40.0 mmt180 -82.3 -17.57 45.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.471 HG21 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.498 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 ' CG2' HD22 ' A' ' 13' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . -122.38 -18.74 6.66 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 36.6 tt0 62.09 162.89 0.08 Allowed 'General case' 0 CA--C 1.577 2.015 0 O-C-N 124.617 1.198 . . . . 0.0 111.863 -175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.4 m -54.3 125.37 19.03 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 123.841 0.857 . . . . 0.0 111.844 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 21.2 mmt180 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.128 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.852 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -131.09 -6.53 3.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 117.221 0.51 . . . . 0.0 111.602 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.45 75.96 0.81 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.219 0.533 . . . . 0.0 110.736 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -125.87 94.66 4.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 153.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.85 122.17 39.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' HG11 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.478 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.541 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.432 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 47.9 m-80 -101.42 153.55 19.58 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.445 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 15.4 t70 -97.34 112.13 24.08 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 126.024 1.729 . . . . 0.0 107.648 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.421 ' H ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.35 -27.3 62.32 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 1.8 pm0 -75.37 -41.54 56.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 80.5 p -92.56 -21.02 20.33 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 121.992 -0.442 . . . . 0.0 111.087 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.23 32.24 32.19 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.544 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 10.8 ptp180 -144.09 179.99 6.86 Favored 'General case' 0 C--O 1.198 -1.62 0 O-C-N 122.29 -0.535 . . . . 0.0 109.947 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 16.6 m -70.95 145.34 50.15 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 118.314 0.506 . . . . 0.0 109.926 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HG2' ' HB2' ' A' ' 40' ' ' ASP . 12.8 mtp180 -83.12 -3.62 57.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.575 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.406 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 HG11 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.38 -19.22 21.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 17.2 mm-40 58.05 -171.42 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.885 0.874 . . . . 0.0 111.748 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 m -74.96 56.28 0.74 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.191 0.996 . . . . 0.0 109.025 175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.857 -177.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.051 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp -175.83 2.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.749 0.419 . . . . 0.0 111.464 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.88 15.44 8.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 109.364 -176.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -100.74 81.41 2.29 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.34 160.77 2.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -92.74 135.38 34.16 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.625 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.417 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.458 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.573 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -98.87 167.31 10.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -94.95 124.93 39.28 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 125.318 1.447 . . . . 0.0 109.526 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 78.6 mmt-85 -73.09 -50.66 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.319 0.58 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.6 mp0 -58.94 -40.39 84.5 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.667 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.4 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 36.8 p -113.45 -7.24 13.45 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 13.84 82.63 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.313 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 17.5 mtp-105 -90.13 -173.24 3.77 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.119 0.568 . . . . 0.0 110.89 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 p -106.11 151.07 25.18 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -101.76 6.72 41.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.184 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.403 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.625 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 55' ' ' LYS . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.512 ' SD ' HD12 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.512 HD12 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . . . -89.74 -25.41 21.16 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 73.78 169.21 0.3 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.423 1.889 . . . . 0.0 111.483 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -62.62 101.95 0.29 Allowed 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.991 0.917 . . . . 0.0 112.115 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.4 ptt-85 . . . . . 0 C--O 1.243 0.747 0 C-N-CA 126.299 1.839 . . . . 0.0 110.969 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt 68.31 62.51 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.78 1.232 . . . . 0.0 111.742 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.582 ' O ' ' HE1' ' A' ' 6' ' ' TYR . . . -167.48 119.39 0.89 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.576 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -82.29 106.72 14.41 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -163.73 163.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.03 107.92 0.35 Allowed 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.782 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.582 ' HE1' ' O ' ' A' ' 2' ' ' ALA . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.475 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.452 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -101.76 167.5 10.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 42' ' ' GLU . 7.2 t70 -83.24 108.8 16.72 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.266 0.0 OUTLIER -72.16 -10.41 59.74 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 4.0 pm0 -90.11 -40.58 12.16 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.44 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 72.4 p -119.9 -20.56 7.49 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.71 9.81 45.33 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.54 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 43.9 mtt180 -70.31 -172.1 0.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.311 0.576 . . . . 0.0 109.864 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -112.39 157.73 20.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.685 -0.634 . . . . 0.0 109.886 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.568 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -97.73 -7.39 30.88 Favored 'General case' 0 C--O 1.215 -0.748 0 O-C-N 122.151 -0.343 . . . . 0.0 111.178 176.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.503 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . -73.14 -30.87 63.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 85' ' ' ARG . 34.1 tt0 70.35 128.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.371 1.869 . . . . 0.0 113.759 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.8 m -97.03 130.64 44.32 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.745 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 83' ' ' GLN . 6.3 mpt_? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp 73.93 -71.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 112.757 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.0 131.41 13.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.274 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 72.44 13.54 5.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.35 1.86 . . . . 0.0 112.509 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.0 t -104.23 107.85 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.4 119.43 15.53 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.57 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.51 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.496 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.31 165.28 17.43 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 15.1 t70 -81.42 126.4 31.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' HB3' ' OE2' ' A' ' 42' ' ' GLU . 28.2 ttp180 -71.89 -28.01 63.23 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.051 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.592 ' OE2' ' HB3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -87.67 -45.86 10.02 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.296 0.57 . . . . 0.0 110.449 -171.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.6 p -109.66 -10.63 14.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.04 -16.29 43.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.048 -0.596 . . . . 0.0 114.38 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.25 155.89 37.71 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 122.626 0.37 . . . . 0.0 111.557 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 m -64.68 136.29 56.81 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 91.2 mtt180 -86.12 0.66 53.01 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.51 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HA ' HD13 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.515 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.62 23.35 8.86 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -69.8 160.29 32.01 Favored 'General case' 0 C--O 1.257 1.456 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.341 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 m -73.29 96.75 2.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.754 0.788 . . . . 0.0 111.718 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 C--N 1.304 -1.387 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.047 179.503 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.473 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.221 -0.685 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp -160.87 125.57 3.63 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.72 84.01 0.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.708 1.255 . . . . 0.0 110.306 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' CD ' ' H1 ' ' A' ' 0' ' ' GLY . 5.8 mm-40 -91.64 3.62 54.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.053 0.93 . . . . 0.0 109.375 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.92 159.76 26.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -84.0 148.79 26.68 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.19 167.1 12.97 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.98 114.85 27.7 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -71.23 -39.57 71.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.866 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.08 -39.2 89.01 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.783 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 18.0 p -115.99 -15.22 11.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.11 0.18 80.98 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.21 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.408 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 18.2 ptt180 -87.82 178.52 6.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.984 0.421 . . . . 0.0 110.167 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.1 m -94.19 148.67 21.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.61 7.76 45.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.431 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.531 ' HZ1' ' CD ' ' A' ' 31' ' ' GLU . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.518 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' HG2' ' HG3' ' A' ' 83' ' ' GLN . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' PHE . . . -91.25 -38.84 12.42 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.424 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 82.7 mt-30 44.52 -171.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.649 -167.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 m -108.7 83.28 1.74 Allowed 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.364 -174.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.238 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -169.74 4.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.899 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 30.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.38 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.45 7.94 38.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.542 0.687 . . . . 0.0 110.587 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -165.31 162.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.01 151.86 28.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.493 ' CZ ' ' HG1' ' A' ' 53' ' ' THR . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.715 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.421 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 4.4 p-10 -97.41 166.72 11.4 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -87.84 107.03 18.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' HD3' ' OE1' ' A' ' 42' ' ' GLU 0.26 0.2 OUTLIER -75.22 -7.9 55.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.618 ' OE1' ' HD3' ' A' ' 41' ' ' ARG . 1.5 mp0 -78.14 -47.56 17.88 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.461 0.648 . . . . 0.0 110.474 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.454 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 50.8 p -121.01 -24.35 5.61 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.24 23.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.44 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.454 ' HG3' ' OG1' ' A' ' 43' ' ' THR . 46.6 mtt180 -82.12 -169.58 2.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 19.3 p -104.9 162.69 13.12 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.465 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -79.87 -6.82 58.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.38 0.537 . . . . 0.0 109.915 177.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.493 ' HG1' ' CZ ' ' A' ' 7' ' ' ARG . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' HZ1' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.715 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 7' ' ' ARG . . . -138.75 -0.02 1.96 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -119.88 9.23 11.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 118.945 -1.102 . . . . 0.0 111.823 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t 47.2 75.15 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.963 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.253 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.461 ' HA2' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.471 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' HB2' ' CB ' ' A' ' 56' ' ' ASP . 25.2 mmt -134.84 -7.85 2.4 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.86 -45.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.313 0.578 . . . . 0.0 110.961 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.549 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS 0.341 28.8 mm-40 87.51 75.82 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 126.859 2.064 . . . . 0.0 113.683 176.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.495 HG23 ' H ' ' A' ' 5' ' ' GLU . 12.1 p -171.03 -166.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.089 -2.559 . . . . 0.0 104.089 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.495 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -116.69 148.02 41.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 119.473 1.033 . . . . 0.0 109.701 172.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.539 ' HB2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.407 HD22 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.546 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -80.24 158.25 26.27 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 16.1 t70 -86.17 119.58 26.62 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.44 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.15 -30.33 66.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.797 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.77 -40.02 29.63 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.491 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 22.8 p -121.25 -11.42 8.81 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.66 12.0 73.14 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.921 -1.133 . . . . 0.0 112.085 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 16.9 mtp-105 -88.45 -155.27 0.32 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.997 0.919 . . . . 0.0 109.631 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -110.64 146.52 36.03 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mmm180 -76.78 -7.8 56.1 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.958 0.344 . . . . 0.0 111.378 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.549 ' HZ2' ' CD ' ' A' ' 3' ' ' GLU . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 57' ' ' GLU . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.428 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.407 ' CG2' HD22 ' A' ' 13' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' CG ' ' HG3' ' A' ' 83' ' ' GLN . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.46 -23.71 11.38 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 80.6 mt-30 51.5 -167.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.207 . . . . 0.0 111.898 -172.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -81.79 30.31 0.37 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 83' ' ' GLN . 19.9 mtm180 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.908 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.407 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.46 0.252 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt -164.24 -58.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 100.29 3.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 3.5 mm-40 -83.36 92.48 7.55 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.093 -172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.15 176.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -78.6 125.64 29.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.247 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -80.87 156.92 25.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -91.09 127.99 36.74 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.966 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.479 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 36.7 mtm180 -73.16 -32.74 65.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.4 mp0 -73.19 -59.05 2.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.264 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.2 p -102.01 -8.1 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.6 11.83 83.61 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.599 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -96.89 -159.11 0.71 Allowed 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.608 -0.348 . . . . 0.0 110.846 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.2 m -93.96 145.69 24.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -88.15 7.03 33.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.628 0.649 . . . . 0.0 112.249 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.55 ' HZ3' ' CG ' ' A' ' 62' ' ' ASP . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.51 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.55 ' CG ' ' HZ3' ' A' ' 58' ' ' LYS . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . -108.4 -14.41 14.67 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -70.64 -62.13 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.118 0.485 . . . . 0.0 109.809 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m -103.58 -17.51 15.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 35.1 mtm-85 . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.861 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.572 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -107.79 -64.84 1.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.79 72.42 0.13 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.19 13.55 3.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.09 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.13 137.93 20.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.649 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.0 137.72 53.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.422 ' CD1' ' HE3' ' A' ' 60' ' ' MET . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.477 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.454 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.406 HD22 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.56 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.93 149.96 29.2 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.38 119.57 25.26 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -71.3 -30.34 66.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.328 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.02 -40.32 46.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.448 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -111.53 -18.83 12.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 8.7 78.3 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.956 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 46' ' ' SER . 26.5 ptt-85 -96.9 -178.24 4.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 14.4 m -76.81 139.03 40.21 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 170.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -74.84 -2.71 27.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.3 0.955 . . . . 0.0 111.576 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HG3' HD22 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.518 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.422 ' HE3' ' CD1' ' A' ' 6' ' ' TYR . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.518 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.421 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 78' ' ' THR . 2.4 t-20 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.517 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.405 ' C ' ' HD2' ' A' ' 75' ' ' ARG . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.538 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.36 19.62 5.05 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -94.2 150.21 20.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.5 m -53.34 108.9 0.38 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.493 0.663 . . . . 0.0 112.636 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.1 177.876 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.112 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 93.8 mtp -138.38 21.64 2.75 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.48 -15.74 12.54 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.829 0.823 . . . . 0.0 109.492 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -92.71 0.47 57.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.118 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.25 126.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.715 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -101.23 146.21 27.83 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.684 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.803 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.549 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -80.48 161.31 24.93 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' OD2' ' HB2' ' A' ' 42' ' ' GLU . 35.1 t0 -81.99 132.87 35.26 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.055 -171.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 52.1 mmt-85 -74.36 -27.05 60.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.326 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 48.4 mt-10 -73.58 -61.65 1.76 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.665 0.603 . . . . 0.0 110.751 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -118.39 -13.14 9.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.91 0.48 66.21 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.669 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -70.75 176.61 4.09 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.631 0.772 . . . . 0.0 111.025 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.1 m -78.4 130.9 36.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -87.31 2.01 51.53 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.166 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 1' ' ' MET . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.504 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.803 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.504 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 64' ' ' ILE . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.549 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -100.82 25.52 7.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -73.52 89.78 1.71 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.8 m -144.95 106.18 4.2 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 C--N 1.311 -1.088 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.541 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.497 -1.055 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp -164.92 72.99 0.21 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 79.3 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.446 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' CD ' ' H2 ' ' A' ' 0' ' ' GLY . 8.6 mp0 -87.42 -27.47 22.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 123.004 1.383 . . . . 0.0 108.053 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.02 170.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 136.04 38.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.953 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.511 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -83.15 167.74 17.48 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.29 108.33 21.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -71.51 -33.55 69.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.899 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.15 -45.56 80.56 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.821 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.9 p -104.07 -5.07 22.45 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 21.17 77.28 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.962 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -108.86 -164.94 0.98 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.3 t -117.35 158.57 24.18 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -102.3 3.87 38.54 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' HZ3' ' CG ' ' A' ' 56' ' ' ASP . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' CG ' ' HZ3' ' A' ' 55' ' ' LYS . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.461 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 60' ' ' MET . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.559 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.528 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -116.84 34.84 4.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.1 107.18 0.05 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 126.203 1.801 . . . . 0.0 114.777 -175.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -64.86 107.09 1.37 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.915 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.469 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm -149.59 23.84 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.98 89.11 0.7 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -103.22 82.12 2.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.55 155.49 38.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.495 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.53 103.14 1.98 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.511 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 ' HG1' ' HB2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.542 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.439 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.542 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.7 160.45 14.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -96.95 108.3 20.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.64 -6.94 47.73 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.31 -49.81 5.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -88.45 -15.67 34.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.07 -5.79 82.95 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.001 -0.619 . . . . 0.0 114.107 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.92 166.7 10.98 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -64.1 140.02 58.83 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.857 0.863 . . . . 0.0 111.137 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.87 -9.96 59.07 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.511 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.53 24.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 29.4 tt0 66.8 -69.02 0.13 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.924 2.49 . . . . 0.0 112.193 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 p -155.09 -95.96 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.172 0.51 . . . . 0.0 112.084 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 124.459 1.104 . . . . 0.0 109.71 -177.432 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.543 ' H2 ' ' CG ' ' A' ' 56' ' ' ASP . . . . . . . . 0 CA--C 1.482 -1.982 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp -74.62 -25.51 59.28 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.24 153.26 18.7 Favored 'General case' 0 C--O 1.257 1.472 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.91 6.97 47.1 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.973 0.796 . . . . 0.0 111.358 -175.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -62.77 119.74 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.122 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.49 142.91 27.29 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.201 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.524 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' OE2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.524 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.95 154.11 27.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.44 107.94 20.51 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -71.24 -42.96 68.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.91 0.862 . . . . 0.0 108.934 -173.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.75 -37.51 68.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.107 -1.86 . . . . 0.0 113.355 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.1 p -118.74 -6.39 10.61 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.83 70.4 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.239 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' HB3' ' H ' ' A' ' 46' ' ' SER . 18.1 mtp-105 -108.66 -159.12 0.67 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.315 0.646 . . . . 0.0 109.927 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 16.4 m -103.31 150.0 24.19 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 172.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -69.71 -16.65 63.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.611 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.543 ' CG ' ' H2 ' ' A' ' 0' ' ' GLY . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.431 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.431 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.727 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.8 -5.0 35.78 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.12 -170.27 0.19 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.803 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t 61.41 -151.06 0.39 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 122.398 -0.189 . . . . 0.0 110.696 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -70.35 -26.88 63.95 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.54 166.26 16.38 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 16.0 mm-40 62.23 75.98 0.38 Allowed 'General case' 0 C--O 1.252 1.213 0 CA-C-O 122.933 1.349 . . . . 0.0 109.469 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.8 t -122.87 146.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.594 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.462 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -109.28 143.54 38.63 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.462 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.497 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.512 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.439 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.439 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.512 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -86.58 164.47 16.85 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -96.16 114.67 26.38 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.13 -30.57 66.66 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.241 0.544 . . . . 0.0 111.09 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.19 -43.91 55.42 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.509 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.2 p -115.23 -6.4 12.41 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 12.66 82.81 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.943 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -86.68 -177.66 6.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 111.498 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -103.12 138.84 39.41 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -92.74 21.76 5.3 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 3' ' ' GLU . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.51 ' HZ1' ' CG ' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' CG ' ' HZ1' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.577 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.497 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.92 -16.16 25.51 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -87.95 52.28 2.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 m -59.59 107.29 0.57 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.531 1.133 . . . . 0.0 111.471 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.352 -179.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.419 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.512 -0.152 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.298 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt 175.96 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.2 86.16 2.4 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.477 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.419 ' CD ' ' H1 ' ' A' ' 0' ' ' GLY . 0.4 OUTLIER -88.43 95.05 10.06 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 122.543 1.163 . . . . 0.0 109.548 -176.315 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.95 150.14 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.482 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.85 120.64 1.34 Allowed 'General case' 0 C--O 1.253 1.261 0 O-C-N 125.136 1.523 . . . . 0.0 111.355 -177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.452 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.673 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.402 HD22 ' CG2' ' A' ' 77' ' ' ILE . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.417 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.421 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.421 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.403 HD13 HG23 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.61 149.56 24.23 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.36 148.83 40.93 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.72 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -72.82 -39.92 66.23 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 123.216 0.323 . . . . 0.0 111.335 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -84.23 -48.15 10.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.342 0.592 . . . . 0.0 111.185 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.4 p -88.13 -16.51 33.26 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.74 26.62 71.19 Favored Glycine 0 C--O 1.222 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.928 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -122.68 161.2 24.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -173.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -59.35 119.52 7.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 125.684 1.593 . . . . 0.0 111.805 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -86.36 29.16 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 HG23 HD13 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.673 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.402 ' CG2' HD22 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 7' ' ' ARG . . . -102.66 -18.23 15.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 77.7 mt-30 60.81 -164.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.834 0.709 . . . . 0.0 110.861 -174.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -73.47 95.35 2.22 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.96 -0.463 . . . . 0.0 112.117 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.027 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.526 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.218 -0.845 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt -176.19 -54.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 116.3 11.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' CD ' ' H1 ' ' A' ' 0' ' ' GLY . 5.3 mm-40 -92.21 58.52 3.3 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.272 1.034 . . . . 0.0 109.465 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.5 t -137.65 130.33 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.37 150.72 40.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.57 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 34' ' ' ASP . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -107.55 165.62 11.28 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -100.46 139.42 36.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.472 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -31.44 64.36 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.71 -56.98 12.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.923 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.6 p -115.33 -25.44 7.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.37 20.99 15.95 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.507 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -106.52 -174.29 2.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 t -77.67 156.45 30.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -76.49 -3.12 35.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' HB3' ' OE1' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.457 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.408 ' SD ' HD12 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.553 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.776 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 HD12 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.81 51.16 1.66 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.9 pt20 -44.11 -68.87 0.16 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 126.366 1.866 . . . . 0.0 115.259 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 16.9 m -87.54 87.71 7.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.609 0 C-N-CA 124.526 1.13 . . . . 0.0 110.441 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.332 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -56.29 127.89 33.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.975 0.51 . . . . 0.0 110.648 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 87.06 0.61 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.54 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 17.6 mm-40 -93.17 74.18 4.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.036 0.922 . . . . 0.0 110.395 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -167.04 166.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.05 112.86 23.1 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' THR . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 14.5 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.494 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' CG ' ' HG1' ' A' ' 53' ' ' THR . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -103.01 153.68 20.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -74.63 142.29 44.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.703 ' NH2' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.18 -7.08 44.31 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.258 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.703 ' HB2' ' NH2' ' A' ' 41' ' ' ARG . 31.0 tt0 -86.7 -62.96 1.39 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.505 0.669 . . . . 0.0 110.88 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 p -121.05 -0.72 9.95 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.99 89.7 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.691 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -61.69 139.44 58.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.625 0.37 . . . . 0.0 110.347 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 p -63.61 144.82 56.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.231 0.538 . . . . 0.0 111.798 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? -99.95 5.3 45.23 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 122.063 -0.398 . . . . 0.0 111.382 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.54 ' HZ2' ' CD ' ' A' ' 3' ' ' GLU . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.405 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' VAL . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.08 22.97 6.58 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.56 ' HG3' ' H ' ' A' ' 84' ' ' SER . 7.8 tp-100 -148.59 -154.22 0.54 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.56 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 6.5 m -46.79 114.22 0.8 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.895 1.278 . . . . 0.0 112.888 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.031 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm 73.33 80.82 0.13 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.25 -62.61 0.42 Allowed 'General case' 0 CA--C 1.473 -2.005 0 C-N-CA 125.957 1.703 . . . . 0.0 111.678 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 7.0 tp10 -94.16 159.26 15.22 Favored 'General case' 1 N--CA 1.369 -4.482 0 CA-C-N 113.118 -1.856 . . . . 0.0 106.905 -174.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 75.4 t 83.41 109.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.368 0 C-N-CA 125.568 1.547 . . . . 0.0 111.201 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 1.4 pm0 -63.89 156.12 28.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.765 -2.016 . . . . 0.0 115.403 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.439 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' SG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 7.7 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.405 ' HA ' ' OE2' ' A' ' 24' ' ' GLU . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.47 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.47 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.408 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -87.76 148.22 24.82 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.04 144.87 40.58 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.307 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.5 -47.04 51.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.29 -53.27 9.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.838 -170.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 35.4 p -92.28 -17.15 25.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.92 0.75 70.36 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.859 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 15.2 ptm180 -85.62 157.21 20.41 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.461 -0.435 . . . . 0.0 111.616 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 132.31 52.6 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -94.96 4.36 53.89 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' HZ2' ' CD ' ' A' ' 5' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.506 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.491 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.454 ' HG3' ' H ' ' A' ' 84' ' ' SER . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.05 -16.34 41.02 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.21 -28.88 25.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.099 0.476 . . . . 0.0 111.023 174.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.454 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 20.2 m -99.81 100.88 11.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.548 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.551 ' H1 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.214 -1.14 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 tpp -117.25 -66.08 1.12 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 117.429 0.614 . . . . 0.0 110.777 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -5.02 21.99 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.139 0.971 . . . . 0.0 109.866 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' CD ' ' H1 ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -122.59 72.85 1.09 Allowed 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.573 1.654 . . . . 0.0 107.23 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.18 156.59 3.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 111.473 -2.603 . . . . 0.0 108.977 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -56.74 130.18 44.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -172.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB2' ' OD2' ' A' ' 73' ' ' ASP . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.47 ' CG ' ' HZ3' ' A' ' 36' ' ' LYS . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.406 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.47 ' HZ3' ' CG ' ' A' ' 19' ' ' ASP . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -80.88 156.95 25.81 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 18.2 t70 -91.75 111.62 23.22 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.316 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.64 ' HD2' ' OE1' ' A' ' 42' ' ' GLU 0.406 0.5 OUTLIER -73.5 -7.89 53.67 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 177.405 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.64 ' OE1' ' HD2' ' A' ' 41' ' ' ARG . 1.6 mp0 -80.78 -57.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.866 0.365 . . . . 0.0 111.496 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.3 p -110.35 -3.56 16.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.01 18.1 70.58 Favored Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.127 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -103.07 -151.58 0.43 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -106.19 147.71 28.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 20.3 mmm180 -78.86 -7.24 57.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.533 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.454 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 14' ' ' ALA . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' OE2' ' HB3' ' A' ' 83' ' ' GLN . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 7' ' ' ARG . . . -76.61 -8.21 56.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.508 ' HB3' ' OE2' ' A' ' 81' ' ' GLU . 7.1 tt0 -72.43 -19.93 61.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.462 ' C ' ' HD2' ' A' ' 85' ' ' ARG . 19.8 m 69.29 64.31 0.28 Allowed 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.229 1.411 . . . . 0.0 114.201 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.462 ' HD2' ' C ' ' A' ' 84' ' ' SER . 3.5 mpt_? . . . . . 0 C--N 1.314 -0.961 0 C-N-CA 123.957 0.903 . . . . 0.0 108.919 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 53' ' ' THR . 12.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 79' ' ' VAL . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 . . . . . 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HG3' HG22 ' A' ' 38' ' ' ILE . 40.0 mmt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.462 ' HA ' HE21 ' A' ' 70' ' ' GLN . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 67' ' ' MET . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 77' ' ' ILE . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 72' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 10' ' ' VAL . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 7' ' ' ARG . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 14' ' ' ALA . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.564 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.401 HG12 ' HA2' ' A' ' 50' ' ' GLY . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 38' ' ' ILE . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' OE2' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 61' ' ' ARG . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.451 ' HA ' HE21 ' A' ' 70' ' ' GLN . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 67' ' ' MET . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.243 0.727 0 CA-C-O 121.231 0.538 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CB ' ' HG3' ' A' ' 60' ' ' MET . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 13' ' ' LEU . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 47' ' ' ARG . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 . . . . . 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.642 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.585 0.231 . . . . 0.0 111.178 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.442 ' SD ' HD11 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 8' ' ' CYS . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 64' ' ' ILE . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.462 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.404 ' CD ' ' HG3' ' A' ' 67' ' ' MET . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.725 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 77' ' ' ILE . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 121.129 0.49 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HZ3' ' HB3' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.725 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 61' ' ' ARG . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 13' ' ' LEU . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.57 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 37' ' ' ILE . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.428 HD13 HD22 ' A' ' 22' ' ' LEU . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.498 0.189 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 77' ' ' ILE . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 72' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.431 -1.425 0 CA-C-O 121.236 0.541 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 37' ' ' ILE . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 55' ' ' LYS . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 13' ' ' LEU . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD2' ' HA ' ' A' ' 59' ' ' ALA . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.475 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.562 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.733 0.301 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.575 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.675 0 CA-C-O 120.808 0.337 . . . . 0.0 111.684 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.81 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 55' ' ' LYS . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.497 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB3' HD21 ' A' ' 33' ' ' LEU . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.81 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 37' ' ' ILE . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' LEU . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.513 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 CA-C-O 120.854 0.359 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 79' ' ' VAL . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 17' ' ' THR . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD22 ' A' ' 13' ' ' LEU . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.771 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.513 ' H ' ' HE ' ' A' ' 75' ' ' ARG . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 10' ' ' VAL . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 79' ' ' VAL . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 HG21 ' A' ' 17' ' ' THR . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.467 HG21 HD22 ' A' ' 13' ' ' LEU . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 37' ' ' ILE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.422 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 22' ' ' LEU . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 . . . . . 0 C--O 1.222 -0.376 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.441 HG12 HG12 ' A' ' 79' ' ' VAL . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.441 HG12 HG12 ' A' ' 64' ' ' ILE . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.253 1.261 0 CA-C-O 121.5 0.667 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.465 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.457 ' HD2' ' HB3' ' A' ' 51' ' ' PHE . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 17' ' ' THR . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.414 HG21 HD22 ' A' ' 13' ' ' LEU . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 37' ' ' ILE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.502 HD13 HD22 ' A' ' 22' ' ' LEU . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 7' ' ' ARG . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' HD11 ' A' ' 33' ' ' LEU . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.685 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.414 ' CG2' HD23 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.567 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 38' ' ' ILE . 19.2 mmm180 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.795 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 17' ' ' THR . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 HG21 HD22 ' A' ' 13' ' ' LEU . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' THR . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 60.7 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 18' ' ' THR . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 37' ' ' ILE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD13 HD22 ' A' ' 22' ' ' LEU . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 26' ' ' PHE . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.4 pm0 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.626 ' HG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 52.0 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 37' ' ' ILE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 HD22 ' A' ' 22' ' ' LEU . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.626 ' HE2' ' HG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.488 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 53' ' ' THR . 5.2 pt-20 . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 17' ' ' THR . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 HG21 HD22 ' A' ' 13' ' ' LEU . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 5' ' ' GLU . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' HE2' ' A' ' 58' ' ' LYS . 28.1 ttt -176.26 -49.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.84 99.68 3.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.36 106.25 18.11 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLU . 10.9 p -165.4 174.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 53' ' ' THR . 12.0 tt0 -62.2 119.98 10.05 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 79' ' ' VAL . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.61 164.14 12.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.58 108.64 21.38 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 47.6 mtm180 -71.39 -42.72 68.02 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.878 0.847 . . . . 0.0 108.759 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 3.2 mp0 -54.86 -46.05 74.65 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 113.026 -1.897 . . . . 0.0 113.279 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.8 p -110.4 -11.06 14.55 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.1 56.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.711 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -106.65 -164.81 1.02 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 t -97.06 162.93 13.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HG3' HG22 ' A' ' 38' ' ' ILE . 40.0 mmt180 -82.3 -17.57 45.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.462 ' HA ' HE21 ' A' ' 70' ' ' GLN . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 67' ' ' MET . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 77' ' ' ILE . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 72' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 10' ' ' VAL . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -122.38 -18.74 6.66 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 36.6 tt0 62.09 162.89 0.08 Allowed 'General case' 0 CA--C 1.577 2.015 0 O-C-N 124.617 1.198 . . . . 0.0 111.863 -175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.4 m -54.3 125.37 19.03 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 123.841 0.857 . . . . 0.0 111.844 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 21.2 mmt180 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.128 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.852 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -131.09 -6.53 3.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 117.221 0.51 . . . . 0.0 111.602 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.45 75.96 0.81 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.219 0.533 . . . . 0.0 110.736 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -125.87 94.66 4.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 153.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.85 122.17 39.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 47.9 m-80 -101.42 153.55 19.58 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 15.4 t70 -97.34 112.13 24.08 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 126.024 1.729 . . . . 0.0 107.648 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.35 -27.3 62.32 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 1.8 pm0 -75.37 -41.54 56.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 80.5 p -92.56 -21.02 20.33 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 121.992 -0.442 . . . . 0.0 111.087 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.23 32.24 32.19 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.544 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 10.8 ptp180 -144.09 179.99 6.86 Favored 'General case' 0 C--O 1.198 -1.62 0 O-C-N 122.29 -0.535 . . . . 0.0 109.947 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 16.6 m -70.95 145.34 50.15 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 118.314 0.506 . . . . 0.0 109.926 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ASP . 12.8 mtp180 -83.12 -3.62 57.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.575 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -93.38 -19.22 21.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 17.2 mm-40 58.05 -171.42 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.885 0.874 . . . . 0.0 111.748 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 m -74.96 56.28 0.74 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.191 0.996 . . . . 0.0 109.025 175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.857 -177.88 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.051 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 2' ' ' ALA . 22.4 ptp -175.83 2.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.749 0.419 . . . . 0.0 111.464 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 1' ' ' MET . . . -124.88 15.44 8.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 109.364 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -100.74 81.41 2.29 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.34 160.77 2.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -92.74 135.38 34.16 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 14' ' ' ALA . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.564 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.401 HG12 ' HA2' ' A' ' 50' ' ' GLY . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -98.87 167.31 10.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -94.95 124.93 39.28 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 125.318 1.447 . . . . 0.0 109.526 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 78.6 mmt-85 -73.09 -50.66 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.319 0.58 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.6 mp0 -58.94 -40.39 84.5 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.667 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.402 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 36.8 p -113.45 -7.24 13.45 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 13.84 82.63 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.313 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 17.5 mtp-105 -90.13 -173.24 3.77 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.119 0.568 . . . . 0.0 110.89 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 p -106.11 151.07 25.18 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -101.76 6.72 41.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.184 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 38' ' ' ILE . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' OE2' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 61' ' ' ARG . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.451 ' HA ' HE21 ' A' ' 70' ' ' GLN . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 67' ' ' MET . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -89.74 -25.41 21.16 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 73.78 169.21 0.3 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.423 1.889 . . . . 0.0 111.483 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -62.62 101.95 0.29 Allowed 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.991 0.917 . . . . 0.0 112.115 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.4 ptt-85 . . . . . 0 C--O 1.243 0.747 0 C-N-CA 126.299 1.839 . . . . 0.0 110.969 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt 68.31 62.51 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.78 1.232 . . . . 0.0 111.742 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' O ' ' HE1' ' A' ' 6' ' ' TYR . . . -167.48 119.39 0.89 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.576 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -82.29 106.72 14.41 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -163.73 163.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.03 107.92 0.35 Allowed 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.782 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.579 ' HE1' ' O ' ' A' ' 2' ' ' ALA . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 13' ' ' LEU . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 47' ' ' ARG . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -101.76 167.5 10.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 42' ' ' GLU . 7.2 t70 -83.24 108.8 16.72 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.266 0.0 OUTLIER -72.16 -10.41 59.74 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 4.0 pm0 -90.11 -40.58 12.16 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 72.4 p -119.9 -20.56 7.49 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.71 9.81 45.33 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.54 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 43.9 mtt180 -70.31 -172.1 0.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.311 0.576 . . . . 0.0 109.864 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -112.39 157.73 20.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.685 -0.634 . . . . 0.0 109.886 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.642 ' HE ' ' HA ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -97.73 -7.39 30.88 Favored 'General case' 0 C--O 1.215 -0.748 0 O-C-N 122.151 -0.343 . . . . 0.0 111.178 176.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.442 ' SD ' HD11 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -73.14 -30.87 63.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 85' ' ' ARG . 34.1 tt0 70.35 128.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.371 1.869 . . . . 0.0 113.759 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.8 m -97.03 130.64 44.32 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.745 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 83' ' ' GLN . 6.3 mpt_? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp 73.93 -71.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 112.757 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.0 131.41 13.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.274 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 72.44 13.54 5.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.35 1.86 . . . . 0.0 112.509 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.0 t -104.23 107.85 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.4 119.43 15.53 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.31 165.28 17.43 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 15.1 t70 -81.42 126.4 31.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HB3' ' OE2' ' A' ' 42' ' ' GLU . 28.2 ttp180 -71.89 -28.01 63.23 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.051 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' OE2' ' HB3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -87.67 -45.86 10.02 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.296 0.57 . . . . 0.0 110.449 -171.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.6 p -109.66 -10.63 14.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.04 -16.29 43.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.048 -0.596 . . . . 0.0 114.38 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.25 155.89 37.71 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 122.626 0.37 . . . . 0.0 111.557 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 m -64.68 136.29 56.81 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 91.2 mtt180 -86.12 0.66 53.01 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 8' ' ' CYS . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 64' ' ' ILE . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -123.62 23.35 8.86 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -69.8 160.29 32.01 Favored 'General case' 0 C--O 1.257 1.456 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.341 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 m -73.29 96.75 2.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.754 0.788 . . . . 0.0 111.718 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 C--N 1.304 -1.387 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.047 179.503 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.685 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp -160.87 125.57 3.63 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.72 84.01 0.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.708 1.255 . . . . 0.0 110.306 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.64 3.62 54.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.053 0.93 . . . . 0.0 109.375 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.92 159.76 26.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -84.0 148.79 26.68 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.19 167.1 12.97 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.98 114.85 27.7 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -71.23 -39.57 71.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.866 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.08 -39.2 89.01 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.783 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 18.0 p -115.99 -15.22 11.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.11 0.18 80.98 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.21 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 18.2 ptt180 -87.82 178.52 6.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.984 0.421 . . . . 0.0 110.167 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.1 m -94.19 148.67 21.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.61 7.76 45.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' CD ' ' HG3' ' A' ' 67' ' ' MET . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 83' ' ' GLN . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -91.25 -38.84 12.42 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.504 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 82.7 mt-30 44.52 -171.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.649 -167.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 m -108.7 83.28 1.74 Allowed 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.364 -174.838 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.238 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -169.74 4.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.899 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 30.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.38 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.45 7.94 38.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.542 0.687 . . . . 0.0 110.587 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -165.31 162.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.01 151.86 28.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.725 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 77' ' ' ILE . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 4.4 p-10 -97.41 166.72 11.4 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -87.84 107.03 18.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HD3' ' OE1' ' A' ' 42' ' ' GLU 0.26 0.2 OUTLIER -75.22 -7.9 55.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.626 ' OE1' ' HD3' ' A' ' 41' ' ' ARG . 1.5 mp0 -78.14 -47.56 17.88 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.461 0.648 . . . . 0.0 110.474 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 50.8 p -121.01 -24.35 5.61 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.24 23.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.44 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 43' ' ' THR . 46.6 mtt180 -82.12 -169.58 2.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 19.3 p -104.9 162.69 13.12 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -79.87 -6.82 58.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.38 0.537 . . . . 0.0 109.915 177.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HZ3' ' HB3' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' OE1' ' HE2' ' A' ' 60' ' ' MET . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.725 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 61' ' ' ARG . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 13' ' ' LEU . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -138.75 -0.02 1.96 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -119.88 9.23 11.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 118.945 -1.102 . . . . 0.0 111.823 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t 47.2 75.15 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.963 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.253 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.449 ' HA2' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.471 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB2' ' CB ' ' A' ' 56' ' ' ASP . 25.2 mmt -134.84 -7.85 2.4 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.86 -45.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.313 0.578 . . . . 0.0 110.961 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' OE2' ' HA2' ' A' ' 0' ' ' GLY 0.341 28.8 mm-40 87.51 75.82 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 126.859 2.064 . . . . 0.0 113.683 176.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 5' ' ' GLU . 12.1 p -171.03 -166.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.089 -2.559 . . . . 0.0 104.089 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -116.69 148.02 41.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 119.473 1.033 . . . . 0.0 109.701 172.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 37' ' ' ILE . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.428 HD13 HD22 ' A' ' 22' ' ' LEU . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -80.24 158.25 26.27 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 16.1 t70 -86.17 119.58 26.62 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.44 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.15 -30.33 66.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.797 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.77 -40.02 29.63 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.496 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 22.8 p -121.25 -11.42 8.81 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.66 12.0 73.14 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.921 -1.133 . . . . 0.0 112.085 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 16.9 mtp-105 -88.45 -155.27 0.32 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.997 0.919 . . . . 0.0 109.631 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 31.4 m -110.64 146.52 36.03 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mmm180 -76.78 -7.8 56.1 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.958 0.344 . . . . 0.0 111.378 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 77' ' ' ILE . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 72' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 83' ' ' GLN . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.46 -23.71 11.38 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 80.6 mt-30 51.5 -167.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.207 . . . . 0.0 111.898 -172.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -81.79 30.31 0.37 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 83' ' ' GLN . 19.9 mtm180 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.908 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.252 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt -164.24 -58.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 100.29 3.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 92.48 7.55 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.093 -172.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 5' ' ' GLU . 11.3 p -160.15 176.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' H ' HG22 ' A' ' 4' ' ' VAL . 4.4 pt-20 -78.6 125.64 29.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.247 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 37' ' ' ILE . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 55' ' ' LYS . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 13' ' ' LEU . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -80.87 156.92 25.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -91.09 127.99 36.74 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.966 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 36.7 mtm180 -73.16 -32.74 65.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.4 mp0 -73.19 -59.05 2.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.264 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.2 p -102.01 -8.1 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.6 11.83 83.61 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.599 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -96.89 -159.11 0.71 Allowed 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.608 -0.348 . . . . 0.0 110.846 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.2 m -93.96 145.69 24.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -88.15 7.03 33.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.628 0.649 . . . . 0.0 112.249 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD2' ' HA ' ' A' ' 59' ' ' ALA . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -108.4 -14.41 14.67 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -70.64 -62.13 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.118 0.485 . . . . 0.0 109.809 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m -103.58 -17.51 15.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 35.1 mtm-85 . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.861 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.572 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -107.79 -64.84 1.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.79 72.42 0.13 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.19 13.55 3.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.09 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.13 137.93 20.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.649 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.0 137.72 53.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.475 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.562 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.93 149.96 29.2 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.38 119.57 25.26 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -71.3 -30.34 66.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.328 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.02 -40.32 46.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.448 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -111.53 -18.83 12.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 8.7 78.3 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.956 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 46' ' ' SER . 26.5 ptt-85 -96.9 -178.24 4.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 14.4 m -76.81 139.03 40.21 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 170.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -74.84 -2.71 27.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.3 0.955 . . . . 0.0 111.576 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.575 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 83' ' ' GLN . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.36 19.62 5.05 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 8.9 tt0 -94.2 150.21 20.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 174.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.5 m -53.34 108.9 0.38 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.493 0.663 . . . . 0.0 112.636 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.1 177.876 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.112 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 93.8 mtp -138.38 21.64 2.75 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.48 -15.74 12.54 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.829 0.823 . . . . 0.0 109.492 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -92.71 0.47 57.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.118 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.25 126.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.715 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -101.23 146.21 27.83 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.684 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.81 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 55' ' ' LYS . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -80.48 161.31 24.93 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 42' ' ' GLU . 35.1 t0 -81.99 132.87 35.26 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.055 -171.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 52.1 mmt-85 -74.36 -27.05 60.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.326 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 48.4 mt-10 -73.58 -61.65 1.76 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.665 0.603 . . . . 0.0 110.751 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -118.39 -13.14 9.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.91 0.48 66.21 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.669 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -70.75 176.61 4.09 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.631 0.772 . . . . 0.0 111.025 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.1 m -78.4 130.9 36.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -87.31 2.01 51.53 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.166 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.497 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 1' ' ' MET . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.81 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -100.82 25.52 7.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -73.52 89.78 1.71 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.8 m -144.95 106.18 4.2 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 C--N 1.311 -1.088 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.418 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.497 -1.055 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp -164.92 72.99 0.21 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 79.3 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.446 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 8.6 mp0 -87.42 -27.47 22.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 123.004 1.383 . . . . 0.0 108.053 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.02 170.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 136.04 38.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.953 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 37' ' ' ILE . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' LEU . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 91.5 m-20 -83.15 167.74 17.48 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.29 108.33 21.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -71.51 -33.55 69.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.899 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.15 -45.56 80.56 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.821 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.9 p -104.07 -5.07 22.45 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 21.17 77.28 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.962 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -108.86 -164.94 0.98 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 32.3 t -117.35 158.57 24.18 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -102.3 3.87 38.54 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -116.84 34.84 4.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.1 107.18 0.05 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 126.203 1.801 . . . . 0.0 114.777 -175.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -64.86 107.09 1.37 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.915 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.469 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm -149.59 23.84 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.98 89.11 0.7 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -103.22 82.12 2.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.55 155.49 38.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.495 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.53 103.14 1.98 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.513 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.7 160.45 14.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -96.95 108.3 20.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.64 -6.94 47.73 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.31 -49.81 5.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -88.45 -15.67 34.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.07 -5.79 82.95 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.001 -0.619 . . . . 0.0 114.107 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HD3' ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -111.92 166.7 10.98 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -64.1 140.02 58.83 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.857 0.863 . . . . 0.0 111.137 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.87 -9.96 59.07 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -98.12 -10.53 24.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 29.4 tt0 66.8 -69.02 0.13 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.924 2.49 . . . . 0.0 112.193 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 p -155.09 -95.96 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.172 0.51 . . . . 0.0 112.084 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 124.459 1.104 . . . . 0.0 109.71 -177.432 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.982 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp -74.62 -25.51 59.28 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.24 153.26 18.7 Favored 'General case' 0 C--O 1.257 1.472 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.91 6.97 47.1 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.973 0.796 . . . . 0.0 111.358 -175.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -62.77 119.74 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.122 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.49 142.91 27.29 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.201 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 79' ' ' VAL . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 17' ' ' THR . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD22 ' A' ' 13' ' ' LEU . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.95 154.11 27.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.44 107.94 20.51 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -71.24 -42.96 68.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.91 0.862 . . . . 0.0 108.934 -173.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.75 -37.51 68.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.107 -1.86 . . . . 0.0 113.355 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.1 p -118.74 -6.39 10.61 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.83 70.4 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.239 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -108.66 -159.12 0.67 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.315 0.646 . . . . 0.0 109.927 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -103.31 150.0 24.19 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -69.71 -16.65 63.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.771 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.513 ' H ' ' HE ' ' A' ' 75' ' ' ARG . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 10' ' ' VAL . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.8 -5.0 35.78 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.12 -170.27 0.19 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.803 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t 61.41 -151.06 0.39 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 122.398 -0.189 . . . . 0.0 110.696 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -70.35 -26.88 63.95 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.54 166.26 16.38 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 62.23 75.98 0.38 Allowed 'General case' 0 C--O 1.252 1.213 0 CA-C-O 122.933 1.349 . . . . 0.0 109.469 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.8 t -122.87 146.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.594 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -109.28 143.54 38.63 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 79' ' ' VAL . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 HG21 ' A' ' 17' ' ' THR . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 HG21 HD22 ' A' ' 13' ' ' LEU . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 37' ' ' ILE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.422 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 22' ' ' LEU . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -86.58 164.47 16.85 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -96.16 114.67 26.38 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.13 -30.57 66.66 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.241 0.544 . . . . 0.0 111.09 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.19 -43.91 55.42 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.509 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.2 p -115.23 -6.4 12.41 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 12.66 82.81 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.943 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -86.68 -177.66 6.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 111.498 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -103.12 138.84 39.41 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -92.74 21.76 5.3 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.441 HG12 HG12 ' A' ' 79' ' ' VAL . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.441 HG12 HG12 ' A' ' 64' ' ' ILE . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.92 -16.16 25.51 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 73.1 mm-40 -87.95 52.28 2.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 m -59.59 107.29 0.57 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.531 1.133 . . . . 0.0 111.471 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 83' ' ' GLN . 34.2 mtm180 . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.352 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.152 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt 175.96 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.2 86.16 2.4 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.477 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.43 95.05 10.06 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 122.543 1.163 . . . . 0.0 109.548 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.95 150.14 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.482 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.85 120.64 1.34 Allowed 'General case' 0 C--O 1.253 1.261 0 O-C-N 125.136 1.523 . . . . 0.0 111.355 -177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.465 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 17' ' ' THR . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.414 HG21 HD22 ' A' ' 13' ' ' LEU . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 37' ' ' ILE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.502 HD13 HD22 ' A' ' 22' ' ' LEU . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.61 149.56 24.23 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.36 148.83 40.93 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.72 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -72.82 -39.92 66.23 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 123.216 0.323 . . . . 0.0 111.335 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -84.23 -48.15 10.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.342 0.592 . . . . 0.0 111.185 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.4 p -88.13 -16.51 33.26 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.74 26.62 71.19 Favored Glycine 0 C--O 1.222 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.928 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -122.68 161.2 24.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -173.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -59.35 119.52 7.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 125.684 1.593 . . . . 0.0 111.805 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -86.36 29.16 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 7' ' ' ARG . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' HD11 ' A' ' 33' ' ' LEU . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.685 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.414 ' CG2' HD23 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -102.66 -18.23 15.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 77.7 mt-30 60.81 -164.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.834 0.709 . . . . 0.0 110.861 -174.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -73.47 95.35 2.22 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.96 -0.463 . . . . 0.0 112.117 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.027 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.845 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt -176.19 -54.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 116.3 11.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.21 58.52 3.3 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.272 1.034 . . . . 0.0 109.465 -171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.5 t -137.65 130.33 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.37 150.72 40.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.567 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -107.55 165.62 11.28 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -100.46 139.42 36.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.472 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -31.44 64.36 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.71 -56.98 12.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.923 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.6 p -115.33 -25.44 7.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.37 20.99 15.95 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.507 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -106.52 -174.29 2.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 t -77.67 156.45 30.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 38' ' ' ILE . 19.2 mmm180 -76.49 -3.12 35.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.795 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.81 51.16 1.66 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.556 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.9 pt20 -44.11 -68.87 0.16 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 126.366 1.866 . . . . 0.0 115.259 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.556 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 16.9 m -87.54 87.71 7.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.609 0 C-N-CA 124.526 1.13 . . . . 0.0 110.441 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.332 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -56.29 127.89 33.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.975 0.51 . . . . 0.0 110.648 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 87.06 0.61 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 17.6 mm-40 -93.17 74.18 4.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.036 0.922 . . . . 0.0 110.395 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -167.04 166.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.05 112.86 23.1 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 17' ' ' THR . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 HG21 HD22 ' A' ' 13' ' ' LEU . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' THR . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 60.7 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 18' ' ' THR . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 37' ' ' ILE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD13 HD22 ' A' ' 22' ' ' LEU . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -103.01 153.68 20.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -74.63 142.29 44.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.717 ' NH2' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.18 -7.08 44.31 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.258 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.717 ' HB2' ' NH2' ' A' ' 41' ' ' ARG . 31.0 tt0 -86.7 -62.96 1.39 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.505 0.669 . . . . 0.0 110.88 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 p -121.05 -0.72 9.95 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.99 89.7 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.691 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -61.69 139.44 58.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.625 0.37 . . . . 0.0 110.347 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 p -63.61 144.82 56.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.231 0.538 . . . . 0.0 111.798 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? -99.95 5.3 45.23 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 122.063 -0.398 . . . . 0.0 111.382 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 3' ' ' GLU . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 26' ' ' PHE . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.08 22.97 6.58 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' A' ' 84' ' ' SER . 7.8 tp-100 -148.59 -154.22 0.54 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.617 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 6.5 m -46.79 114.22 0.8 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.895 1.278 . . . . 0.0 112.888 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 90.8 mtt180 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm 73.33 80.82 0.13 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.25 -62.61 0.42 Allowed 'General case' 0 CA--C 1.473 -2.005 0 C-N-CA 125.957 1.703 . . . . 0.0 111.678 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 7.0 tp10 -94.16 159.26 15.22 Favored 'General case' 1 N--CA 1.369 -4.482 0 CA-C-N 113.118 -1.856 . . . . 0.0 106.905 -174.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 75.4 t 83.41 109.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.368 0 C-N-CA 125.568 1.547 . . . . 0.0 111.201 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 1.4 pm0 -63.89 156.12 28.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.765 -2.016 . . . . 0.0 115.403 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.626 ' HG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 52.0 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 37' ' ' ILE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 HD22 ' A' ' 22' ' ' LEU . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -87.76 148.22 24.82 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.04 144.87 40.58 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.307 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.5 -47.04 51.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.29 -53.27 9.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.838 -170.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 35.4 p -92.28 -17.15 25.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.92 0.75 70.36 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.859 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.508 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 15.2 ptm180 -85.62 157.21 20.41 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.461 -0.435 . . . . 0.0 111.616 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 132.31 52.6 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -94.96 4.36 53.89 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.626 ' HE2' ' HG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HZ3' ' CD ' ' A' ' 5' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.488 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 84' ' ' SER . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.05 -16.34 41.02 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.426 HE22 ' HB3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -85.21 -28.88 25.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.099 0.476 . . . . 0.0 111.023 174.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.502 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 20.2 m -99.81 100.88 11.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.548 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.427 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.214 -1.14 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 tpp -117.25 -66.08 1.12 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 117.429 0.614 . . . . 0.0 110.777 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -5.02 21.99 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.139 0.971 . . . . 0.0 109.866 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -122.59 72.85 1.09 Allowed 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.573 1.654 . . . . 0.0 107.23 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.18 156.59 3.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 111.473 -2.603 . . . . 0.0 108.977 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 53' ' ' THR . 5.2 pt-20 -56.74 130.18 44.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -172.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 17' ' ' THR . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 HG21 HD22 ' A' ' 13' ' ' LEU . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -80.88 156.95 25.81 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 18.2 t70 -91.75 111.62 23.22 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.316 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' OE1' ' A' ' 42' ' ' GLU 0.406 0.5 OUTLIER -73.5 -7.89 53.67 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 177.405 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.652 ' OE1' ' HD2' ' A' ' 41' ' ' ARG . 1.6 mp0 -80.78 -57.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.866 0.365 . . . . 0.0 111.496 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.3 p -110.35 -3.56 16.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.01 18.1 70.58 Favored Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.127 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -103.07 -151.58 0.43 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -106.19 147.71 28.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 20.3 mmm180 -78.86 -7.24 57.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 5' ' ' GLU . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' A' ' 83' ' ' GLN . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -76.61 -8.21 56.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.516 ' HB3' ' OE2' ' A' ' 81' ' ' GLU . 52.7 tt0 -72.43 -19.93 61.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.471 ' C ' ' HD2' ' A' ' 85' ' ' ARG . 19.8 m 69.29 64.31 0.28 Allowed 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.229 1.411 . . . . 0.0 114.201 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HD2' ' C ' ' A' ' 84' ' ' SER . 3.5 mpt_? . . . . . 0 C--N 1.314 -0.961 0 C-N-CA 123.957 0.903 . . . . 0.0 108.919 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 53' ' ' THR . 12.0 tt0 . . . . . 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 79' ' ' VAL . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.439 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 . . . . . 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HG3' HG22 ' A' ' 38' ' ' ILE . 40.0 mmt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.462 ' HA ' HE21 ' A' ' 70' ' ' GLN . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 67' ' ' MET . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 77' ' ' ILE . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 72' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 10' ' ' VAL . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 7' ' ' ARG . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 . . . . . 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.137 0.494 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 14' ' ' ALA . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.564 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.401 HG12 ' HA2' ' A' ' 50' ' ' GLY . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.223 -0.321 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 38' ' ' ILE . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' OE2' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 61' ' ' ARG . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.451 ' HA ' HE21 ' A' ' 70' ' ' GLN . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 67' ' ' MET . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.243 0.727 0 CA-C-O 121.231 0.538 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' CB ' ' HG3' ' A' ' 60' ' ' MET . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 13' ' ' LEU . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 47' ' ' ARG . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 . . . . . 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.642 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.748 0 CA-C-O 120.585 0.231 . . . . 0.0 111.178 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.442 ' SD ' HD11 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 N--CA 1.431 -1.405 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 . . . . . 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 8' ' ' CYS . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 64' ' ' ILE . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 . . . . . 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 . . . . . 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.462 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.404 ' CD ' ' HG3' ' A' ' 67' ' ' MET . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.725 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 77' ' ' ILE . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 121.129 0.49 . . . . 0.0 109.915 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HB3' ' HZ3' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.725 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 61' ' ' ARG . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 13' ' ' LEU . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.24 0.57 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.446 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 37' ' ' ILE . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.428 HD13 HD22 ' A' ' 22' ' ' LEU . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 . . . . . 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.498 0.189 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 77' ' ' ILE . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 72' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 N--CA 1.431 -1.425 0 CA-C-O 121.236 0.541 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 37' ' ' ILE . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 55' ' ' LYS . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 13' ' ' LEU . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 . . . . . 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD2' ' HA ' ' A' ' 59' ' ' ALA . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.475 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.562 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.733 0.301 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 78' ' ' THR . 2.4 t-20 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.575 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.426 -1.675 0 CA-C-O 120.808 0.337 . . . . 0.0 111.684 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.81 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 55' ' ' LYS . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 . . . . . 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.497 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.429 ' HB3' HD21 ' A' ' 33' ' ' LEU . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.81 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 37' ' ' ILE . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' LEU . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.513 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 . . . . . 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 . . . . . 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . . . . . . 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.658 0 CA-C-O 120.854 0.359 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 79' ' ' VAL . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 17' ' ' THR . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD22 ' A' ' 13' ' ' LEU . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 . . . . . 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.771 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.513 ' H ' ' HE ' ' A' ' 75' ' ' ARG . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 10' ' ' VAL . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 79' ' ' VAL . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 HG21 ' A' ' 17' ' ' THR . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.467 HG21 HD22 ' A' ' 13' ' ' LEU . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 37' ' ' ILE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.449 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.422 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 22' ' ' LEU . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 . . . . . 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 . . . . . 0 C--O 1.222 -0.376 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.441 HG12 HG12 ' A' ' 79' ' ' VAL . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.441 HG12 HG12 ' A' ' 64' ' ' ILE . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.253 1.261 0 CA-C-O 121.5 0.667 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.465 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.457 ' HD2' ' HB3' ' A' ' 51' ' ' PHE . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 17' ' ' THR . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.414 HG21 HD22 ' A' ' 13' ' ' LEU . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 37' ' ' ILE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.502 HD13 HD22 ' A' ' 22' ' ' LEU . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 7' ' ' ARG . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' HD11 ' A' ' 33' ' ' LEU . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.685 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.414 ' CG2' HD23 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.583 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.567 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 . . . . . 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 38' ' ' ILE . 19.2 mmm180 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.795 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 17' ' ' THR . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 HG21 HD22 ' A' ' 13' ' ' LEU . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' THR . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 14.5 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 18' ' ' THR . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 37' ' ' ILE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD13 HD22 ' A' ' 22' ' ' LEU . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 120.879 0.371 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 26' ' ' PHE . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 55' ' ' LYS . 1.4 pm0 . . . . . 0 N--CA 1.43 -1.443 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.626 ' HG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 7.7 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 37' ' ' ILE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 HD22 ' A' ' 22' ' ' LEU . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.626 ' HE2' ' HG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.488 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 53' ' ' THR . 5.2 pt-20 . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 17' ' ' THR . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 HG21 HD22 ' A' ' 13' ' ' LEU . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 5' ' ' GLU . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . . . . . . 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' HE2' ' A' ' 58' ' ' LYS . 28.1 ttt -176.26 -49.37 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.84 99.68 3.3 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.36 106.25 18.11 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 5' ' ' GLU . 10.9 p -165.4 174.56 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 53' ' ' THR . 12.0 tt0 -62.2 119.98 10.05 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 121.345 0.593 . . . . 0.0 110.799 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.561 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 35.5 m-85 -111.24 98.12 7.27 Favored 'General case' 0 C--N 1.267 -3.016 0 CA-C-O 122.172 0.987 . . . . 0.0 109.741 170.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 22.3 tpp180 -85.81 123.33 31.06 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 113.429 -1.714 . . . . 0.0 110.003 -173.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -113.41 144.39 42.87 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 53.2 t80 -104.82 119.95 40.24 Favored 'General case' 0 C--O 1.253 1.27 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 79' ' ' VAL . 46.8 t -116.53 114.0 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -120.37 152.8 16.86 Favored Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' ' 75' ' ' ARG . . . 86.97 43.09 6.1 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 119.506 -1.33 . . . . 0.0 110.715 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.8 mt -90.71 174.99 7.19 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.45 156.62 18.07 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 24.6 m-90 -71.24 -5.97 36.15 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.09 -0.32 28.8 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.241 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 99.0 m -68.54 122.48 18.57 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.323 0.582 . . . . 0.0 110.697 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -103.84 160.71 14.56 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.02 -20.63 62.37 Favored 'General case' 0 C--N 1.309 -1.196 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.853 175.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -63.24 -49.5 73.88 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.467 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 p -74.27 -35.93 63.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.746 0.308 . . . . 0.0 111.286 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.439 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 31.4 tp -60.88 -54.16 48.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.974 178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.5 -57.8 17.56 Favored Glycine 0 CA--C 1.5 -0.885 0 CA-C-N 115.65 -0.704 . . . . 0.0 113.518 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.16 -28.26 69.0 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.75 88.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 80.6 m-85 -87.96 -21.72 24.71 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.72 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 27.0 m -62.27 -24.14 67.11 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.397 0.618 . . . . 0.0 110.497 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.26 -18.25 60.76 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.078 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -104.76 -44.13 4.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.534 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.86 173.16 32.55 Favored Glycine 0 N--CA 1.417 -2.579 0 C-N-CA 118.163 -1.97 . . . . 0.0 115.082 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.65 116.99 6.78 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 125.674 1.59 . . . . 0.0 111.653 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.0 mm -101.77 143.79 14.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 O-C-N 123.691 0.619 . . . . 0.0 110.034 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -114.38 -35.41 4.96 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -159.08 146.92 17.69 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.838 -173.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -155.37 110.75 3.04 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -134.37 139.76 45.84 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -176.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mm -89.57 133.83 30.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.528 -1.215 . . . . 0.0 109.033 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.483 HG22 ' HG3' ' A' ' 47' ' ' ARG . 45.3 mm -87.93 114.8 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -97.61 164.14 12.55 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.503 0.668 . . . . 0.0 112.406 -175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.58 108.64 21.38 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.417 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 47.6 mtm180 -71.39 -42.72 68.02 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.878 0.847 . . . . 0.0 108.759 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 3.2 mp0 -54.86 -46.05 74.65 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 113.026 -1.897 . . . . 0.0 113.279 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.8 p -110.4 -11.06 14.55 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.68 23.1 56.94 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.711 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -106.65 -164.81 1.02 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 t -97.06 162.93 13.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' HG3' HG22 ' A' ' 38' ' ' ILE . 40.0 mmt180 -82.3 -17.57 45.35 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.62 14.53 43.49 Favored Glycine 0 N--CA 1.438 -1.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.002 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 20.0 p90 -156.91 168.03 28.69 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.79 176.48 37.41 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -119.44 141.86 48.75 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 120.656 0.265 . . . . 0.0 110.433 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.0 t -122.61 132.1 71.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 5' ' ' GLU . 31.1 m -110.45 119.94 40.83 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 120.953 0.406 . . . . 0.0 110.574 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -101.08 159.51 15.17 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.864 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -91.53 -22.78 20.19 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.799 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -133.39 148.08 51.8 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -42.26 85.95 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 124.021 0.825 . . . . 0.0 111.955 -178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 3.6 mptp? -74.43 -39.57 62.5 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -31.5 68.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.829 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 55.3 ttp -77.92 -50.06 12.96 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.863 176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -48.4 -58.26 4.87 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.744 0.818 . . . . 0.0 112.286 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -56.63 -38.54 72.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.616 0.722 . . . . 0.0 111.256 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -68.36 -26.41 65.57 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.222 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 60' ' ' MET . 97.4 mt -75.17 -56.28 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.655 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.95 -35.21 79.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 120.702 0.287 . . . . 0.0 111.705 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.49 -24.59 72.47 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.302 -0.475 . . . . 0.0 114.182 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.462 ' HA ' HE21 ' A' ' 70' ' ' GLN . 9.6 mmt -100.72 -25.53 14.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -66.39 115.94 6.86 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.755 0.312 . . . . 0.0 110.716 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.01 -26.38 12.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.608 -0.806 . . . . 0.0 113.421 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.462 HE21 ' HA ' ' A' ' 67' ' ' MET . 28.6 pt20 -88.14 -178.65 6.0 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.362 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.08 142.35 27.65 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 123.156 0.285 . . . . 0.0 110.909 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.452 ' HB3' HG21 ' A' ' 77' ' ' ILE . 5.7 tt -145.09 109.05 4.75 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 81.9 m-20 67.25 27.89 8.21 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.204 1.402 . . . . 0.0 112.871 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.63 11.06 52.09 Favored Glycine 0 C--O 1.241 0.566 0 C-N-CA 119.951 -1.119 . . . . 0.0 114.339 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 12' ' ' GLY . 59.2 ttt-85 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.811 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.6 m120 -65.45 119.06 10.33 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 72' ' ' LEU . 24.3 pt -92.66 147.07 5.62 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.634 -174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.0 m -109.34 115.22 29.57 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 10' ' ' VAL . 45.9 t -116.25 133.82 61.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.09 172.99 13.89 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.291 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.01 135.41 39.97 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 124.493 1.117 . . . . 0.0 109.647 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -122.38 -18.74 6.66 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.654 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 36.6 tt0 62.09 162.89 0.08 Allowed 'General case' 0 CA--C 1.577 2.015 0 O-C-N 124.617 1.198 . . . . 0.0 111.863 -175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.4 m -54.3 125.37 19.03 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 123.841 0.857 . . . . 0.0 111.844 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 83' ' ' GLN . 21.2 mmt180 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.128 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.852 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -131.09 -6.53 3.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 117.221 0.51 . . . . 0.0 111.602 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.45 75.96 0.81 Allowed 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 121.219 0.533 . . . . 0.0 110.736 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -125.87 94.66 4.17 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.19 153.48 10.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -96.85 122.17 39.52 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-O 121.772 0.796 . . . . 0.0 112.378 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 40.2 m-85 -116.39 153.26 32.36 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 170.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 17.2 ttp-105 -144.59 139.84 28.37 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.537 -170.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 79' ' ' VAL . 42.2 t -111.82 143.94 41.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.148 -178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 13.2 t80 -101.64 120.82 40.92 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.7 t -122.49 113.63 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.16 158.06 14.74 Favored Glycine 0 C--N 1.295 -1.695 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.74 56.56 2.74 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.3 mt -87.79 167.83 13.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.098 0.475 . . . . 0.0 112.029 -175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -95.05 -162.37 0.94 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -78.72 -43.1 26.59 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.907 -172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.75 19.17 18.89 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.247 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 m -74.16 118.08 16.7 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 121.364 0.602 . . . . 0.0 110.935 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -111.35 173.25 6.43 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 35' ' ' SER . 19.8 p-10 -71.6 -33.88 69.4 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.068 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -62.15 -55.63 26.84 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.625 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.528 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 17.2 p -62.55 -32.46 73.42 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 50.8 tp -67.55 -38.63 84.44 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -44.48 18.77 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.906 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -63.33 -31.05 72.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.763 0.316 . . . . 0.0 111.233 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.05 85.73 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.265 0.555 . . . . 0.0 110.624 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 86.8 m-85 -88.48 -10.14 50.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 m -65.06 -13.54 58.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.193 0.52 . . . . 0.0 111.361 -178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.84 -26.69 66.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.006 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -100.63 -39.24 7.98 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.75 168.33 34.36 Favored Glycine 0 CA--C 1.492 -1.391 0 C-N-CA 118.234 -1.936 . . . . 0.0 113.516 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.87 127.87 33.38 Favored 'General case' 0 C--O 1.251 1.152 0 O-C-N 124.422 0.719 . . . . 0.0 109.817 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.5 mm -96.51 128.68 47.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.6 mt -83.84 -37.22 22.77 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.454 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 24.5 t70 -174.25 155.83 2.47 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 44.3 t -140.34 141.83 35.64 Favored 'General case' 0 C--N 1.283 -2.32 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 29.9 mmtm -142.33 142.8 32.53 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.2 mm -94.56 118.1 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 168.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.2 mm -87.85 130.64 37.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.109 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.707 -174.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 47.9 m-80 -101.42 153.55 19.58 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.073 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 15.4 t70 -97.34 112.13 24.08 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 126.024 1.729 . . . . 0.0 107.648 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' HD3' ' H ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -72.35 -27.3 62.32 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -175.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 1.8 pm0 -75.37 -41.54 56.12 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.442 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 80.5 p -92.56 -21.02 20.33 Favored 'General case' 0 C--O 1.252 1.223 0 O-C-N 121.992 -0.442 . . . . 0.0 111.087 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.23 32.24 32.19 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.544 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.442 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 10.8 ptp180 -144.09 179.99 6.86 Favored 'General case' 0 C--O 1.198 -1.62 0 O-C-N 122.29 -0.535 . . . . 0.0 109.947 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 16.6 m -70.95 145.34 50.15 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 118.314 0.506 . . . . 0.0 109.926 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 40' ' ' ASP . 12.8 mtp180 -83.12 -3.62 57.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.575 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.4 64.14 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.947 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -141.94 171.19 14.39 Favored 'General case' 0 C--O 1.248 1.002 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.51 -177.49 27.92 Favored Glycine 0 N--CA 1.414 -2.794 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -131.23 142.83 50.22 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 123.069 0.548 . . . . 0.0 109.61 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.0 123.19 70.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.6 m -98.21 124.08 42.61 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.1 0.476 . . . . 0.0 110.846 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -107.11 151.96 24.68 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 124.482 1.113 . . . . 0.0 110.243 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -89.02 -25.9 21.74 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.728 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.6 t0 -109.08 137.97 46.16 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.377 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.94 -41.58 74.39 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.622 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 8.9 ttpp -64.07 -49.3 72.82 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.326 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.9 -33.15 64.37 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 124.176 0.99 . . . . 0.0 112.266 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 51.7 ttp -63.68 -39.87 95.41 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -76.0 -41.57 50.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.901 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -54.31 -36.14 63.42 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.004 0.907 . . . . 0.0 109.232 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -69.7 -38.54 76.99 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.267 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 70.3 mt -75.29 -53.93 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.097 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.8 -18.56 65.44 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.077 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.77 -41.65 3.06 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.772 -0.728 . . . . 0.0 114.19 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -99.62 3.15 45.14 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -65.87 115.74 6.3 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.838 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.32 -4.53 85.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.801 -0.714 . . . . 0.0 114.243 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -75.09 165.12 25.75 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 117.826 0.813 . . . . 0.0 110.52 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.69 140.1 30.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.55 107.66 5.21 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.9 t70 65.17 32.3 10.24 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.8 1.286 . . . . 0.0 111.34 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.82 24.05 39.77 Favored Glycine 0 C--O 1.258 1.615 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.611 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -140.0 137.41 34.65 Favored 'General case' 0 N--CA 1.425 -1.708 0 O-C-N 122.463 -0.433 . . . . 0.0 110.053 175.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -83.71 108.62 16.89 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 173.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -81.25 138.97 18.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.461 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.5 m -100.78 114.92 29.13 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 8' ' ' CYS . 59.4 t -113.34 125.49 70.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.794 -173.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -146.1 172.27 13.66 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.715 0.293 . . . . 0.0 110.751 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' HG2' ' HG2' ' A' ' 83' ' ' GLN . 39.7 tt0 -84.74 113.96 21.69 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.426 0.632 . . . . 0.0 111.215 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -93.38 -19.22 21.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.278 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.504 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 17.2 mm-40 58.05 -171.42 0.1 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.885 0.874 . . . . 0.0 111.748 -176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.5 m -74.96 56.28 0.74 Allowed 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.191 0.996 . . . . 0.0 109.025 175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 115.43 -0.805 . . . . 0.0 108.857 -177.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.051 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' H ' ' H ' ' A' ' 2' ' ' ALA . 22.4 ptp -175.83 2.38 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.749 0.419 . . . . 0.0 111.464 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' A' ' 1' ' ' MET . . . -124.88 15.44 8.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.515 0.674 . . . . 0.0 109.364 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -100.74 81.41 2.29 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -155.34 160.77 2.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -92.74 135.38 34.16 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.252 0.549 . . . . 0.0 110.599 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 17.4 m-85 -118.77 90.25 3.3 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-O 122.905 1.336 . . . . 0.0 110.353 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 56.5 ttm-85 -85.84 125.7 33.49 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.759 -2.019 . . . . 0.0 109.792 -174.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.637 ' SG ' ' HB ' ' A' ' 52' ' ' VAL . 26.6 p -110.02 143.23 40.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 63.0 t80 -95.99 130.61 42.94 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -124.61 113.54 36.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.34 148.49 18.49 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.17 52.07 3.36 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.29 172.19 13.9 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . . . -94.91 -167.51 1.65 Allowed 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -172.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -78.14 -32.33 50.28 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.93 -168.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.39 8.1 7.76 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.042 0.449 . . . . 0.0 111.791 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 14' ' ' ALA . 27.4 m -73.34 117.63 15.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-O 121.2 0.524 . . . . 0.0 111.096 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.4 p -104.06 175.73 5.39 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.3 -20.43 62.2 Favored 'General case' 0 CA--C 1.489 -1.386 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -66.59 -55.25 16.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.564 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.9 m -59.94 -36.32 76.82 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.643 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' O ' ' HD1' ' A' ' 26' ' ' PHE . 35.9 tp -65.56 -49.95 66.96 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.49 -46.61 89.84 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.786 -0.643 . . . . 0.0 113.03 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.4 pt-20 -62.77 -36.86 84.44 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.928 0.364 . . . . 0.0 111.413 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.62 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.3 0.571 . . . . 0.0 111.01 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.485 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 47.7 m-85 -84.34 -10.75 57.33 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.954 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.2 m -69.37 -15.66 63.36 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.141 0.496 . . . . 0.0 111.044 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -79.47 -14.67 58.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.522 0.677 . . . . 0.0 109.454 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -101.49 -39.29 7.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.932 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.21 -169.63 30.07 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 119.481 -1.342 . . . . 0.0 112.254 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.27 130.63 37.92 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.517 0.675 . . . . 0.0 112.215 -177.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mm -101.71 128.0 54.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.617 -172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.02 -43.54 11.04 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -160.29 153.84 22.37 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.531 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.7 t -155.41 128.46 8.16 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -141.79 145.58 34.92 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.58 134.5 26.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.401 HG12 ' HA2' ' A' ' 50' ' ' GLY . 51.7 mm -92.9 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 CA-C-O 122.088 0.947 . . . . 0.0 110.066 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -98.87 167.31 10.83 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.496 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -94.95 124.93 39.28 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 125.318 1.447 . . . . 0.0 109.526 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 78.6 mmt-85 -73.09 -50.66 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.319 0.58 . . . . 0.0 111.155 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.6 mp0 -58.94 -40.39 84.5 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.667 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.402 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 36.8 p -113.45 -7.24 13.45 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.66 13.84 82.63 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.313 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 17.5 mtp-105 -90.13 -173.24 3.77 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.119 0.568 . . . . 0.0 110.89 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.5 p -106.11 151.07 25.18 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -101.76 6.72 41.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 119.501 -0.88 . . . . 0.0 113.184 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.72 26.74 74.32 Favored Glycine 0 C--O 1.24 0.471 0 CA-C-N 115.469 -0.787 . . . . 0.0 114.878 173.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.469 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 34.6 p90 -152.04 169.83 21.4 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 38' ' ' ILE . . . -169.25 -164.25 24.64 Favored Glycine 0 N--CA 1.423 -2.23 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -142.26 155.74 45.25 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 116.924 0.362 . . . . 0.0 111.698 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.637 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 48.8 t -126.0 120.05 56.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 42.7 m -98.62 122.23 41.56 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 77.6 m-85 -103.96 173.77 6.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HB3' ' OE2' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -111.27 -21.89 11.65 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -104.6 141.7 35.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.173 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.588 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.3 pt-20 -81.22 -32.41 33.46 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.396 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -59.6 -52.51 65.22 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.512 0.508 . . . . 0.0 110.306 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.04 -32.43 73.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.044 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 64' ' ' ILE . 15.5 tmm? -73.15 -44.98 59.21 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.276 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 61' ' ' ARG . 5.7 mmt85 -62.16 -46.11 90.44 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.044 0.45 . . . . 0.0 110.398 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.92 -25.93 65.72 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.029 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.33 -28.89 53.29 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.229 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 HD11 ' SD ' ' A' ' 60' ' ' MET . 84.8 mt -63.96 -58.54 6.9 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.164 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.11 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.84 -16.31 58.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.445 0.64 . . . . 0.0 111.731 -177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.54 -14.59 82.3 Favored Glycine 0 N--CA 1.439 -1.153 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.847 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.451 ' HA ' HE21 ' A' ' 70' ' ' GLN . 15.9 mmt -120.53 -26.35 5.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -64.35 116.62 6.24 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.222 0.609 . . . . 0.0 111.432 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.74 -21.58 40.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.52 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 67' ' ' MET . 24.3 pt20 -88.92 175.65 7.35 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.517 -176.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.24 135.29 34.12 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.1 tp -136.17 109.52 7.87 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 173.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.8 t70 67.84 27.92 7.21 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.425 1.107 . . . . 0.0 111.727 174.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.68 12.52 55.59 Favored Glycine 0 C--O 1.249 1.041 0 C-N-CA 120.531 -0.843 . . . . 0.0 113.121 175.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 24.9 tpt85 -139.9 141.8 36.53 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -87.19 119.16 27.14 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.492 0.663 . . . . 0.0 109.252 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.5 pt -94.14 150.72 3.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.673 -1.149 . . . . 0.0 112.683 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.2 m -114.29 125.32 53.76 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 t -124.29 140.18 48.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' OD1' ' HB3' ' A' ' 9' ' ' PHE . 27.0 p-10 -155.09 172.24 18.45 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -80.71 125.88 30.59 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 121.99 -0.444 . . . . 0.0 110.389 -177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -89.74 -25.41 21.16 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 73.78 169.21 0.3 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.423 1.889 . . . . 0.0 111.483 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.1 m -62.62 101.95 0.29 Allowed 'General case' 0 C--O 1.246 0.91 0 C-N-CA 123.991 0.917 . . . . 0.0 112.115 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.4 ptt-85 . . . . . 0 C--O 1.243 0.747 0 C-N-CA 126.299 1.839 . . . . 0.0 110.969 179.907 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt 68.31 62.51 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.78 1.232 . . . . 0.0 111.742 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.579 ' O ' ' HE1' ' A' ' 6' ' ' TYR . . . -167.48 119.39 0.89 Allowed 'General case' 0 C--O 1.207 -1.167 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.576 177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -82.29 106.72 14.41 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -163.73 163.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.03 107.92 0.35 Allowed 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.494 0.718 . . . . 0.0 110.782 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.579 ' HE1' ' O ' ' A' ' 2' ' ' ALA . 14.7 m-85 -100.02 134.6 42.69 Favored 'General case' 0 CA--C 1.484 -1.579 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 16.9 tpt180 -91.56 129.57 37.51 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 172.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -113.8 143.6 44.39 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -102.1 125.96 48.93 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.2 t -128.6 113.8 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.28 165.61 13.7 Favored Glycine 0 C--N 1.298 -1.577 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.53 44.93 8.24 Favored Glycine 0 CA--C 1.5 -0.871 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 81.3 mt -80.86 174.77 11.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.521 0.677 . . . . 0.0 112.085 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -110.39 -173.5 2.26 Favored 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.402 -174.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 m95 -78.9 -37.94 38.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.294 0.569 . . . . 0.0 109.774 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 8.13 19.47 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.489 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.415 HG21 HD22 ' A' ' 13' ' ' LEU . 26.5 m -80.99 117.93 22.03 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 121.728 0.775 . . . . 0.0 110.892 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -128.03 172.48 10.9 Favored 'General case' 0 CA--C 1.452 -2.813 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -60.2 -37.55 80.59 Favored 'General case' 0 C--N 1.275 -2.632 0 O-C-N 124.636 1.21 . . . . 0.0 109.791 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -71.61 -52.74 16.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.89 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 p -66.3 -28.01 68.36 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.5 tp -76.92 -41.36 43.8 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.82 -51.67 55.72 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.045 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 44.9 mm-40 -65.04 -27.1 68.57 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.21 -39.11 93.7 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 84.2 m-85 -89.91 -15.2 32.59 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 60.9 p -67.55 -16.17 64.05 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.423 0.63 . . . . 0.0 112.046 -175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.41 -17.89 60.74 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.834 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 90.9 m-85 -98.93 -40.15 8.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.463 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.33 164.2 37.05 Favored Glycine 0 CA--C 1.492 -1.368 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -67.65 120.03 13.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 121.395 0.616 . . . . 0.0 109.585 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.5 mm -79.83 125.41 38.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.782 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.97 -40.51 22.09 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -162.22 160.2 26.7 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -154.03 120.59 5.51 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -136.99 125.24 23.17 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -73.87 143.74 13.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.408 HG22 ' HG3' ' A' ' 47' ' ' ARG . 49.9 mm -81.59 117.51 27.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -101.76 167.5 10.05 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.243 1.02 . . . . 0.0 113.719 -173.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 42' ' ' GLU . 7.2 t70 -83.24 108.8 16.72 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 174.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . 0.266 0.0 OUTLIER -72.16 -10.41 59.74 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -174.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HG2' ' OD1' ' A' ' 40' ' ' ASP . 4.0 pm0 -90.11 -40.58 12.16 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 72.4 p -119.9 -20.56 7.49 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.71 9.81 45.33 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 119.923 -1.132 . . . . 0.0 113.54 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 43.9 mtt180 -70.31 -172.1 0.54 Allowed 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.311 0.576 . . . . 0.0 109.864 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.5 m -112.39 157.73 20.68 Favored 'General case' 0 C--N 1.308 -1.197 0 O-C-N 121.685 -0.634 . . . . 0.0 109.886 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.642 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -97.73 -7.39 30.88 Favored 'General case' 0 C--O 1.215 -0.748 0 O-C-N 122.151 -0.343 . . . . 0.0 111.178 176.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.05 -0.14 58.84 Favored Glycine 0 C--O 1.24 0.47 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.586 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -147.68 164.33 33.88 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -155.8 175.85 33.49 Favored Glycine 0 N--CA 1.426 -2.011 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.6 136.33 50.56 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.51 143.38 25.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.0 m -110.5 125.98 53.89 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.359 0.6 . . . . 0.0 112.502 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -112.8 151.15 30.69 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.414 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.8 ptmm? -83.73 -38.68 21.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -117.1 159.01 23.23 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.735 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -81.24 -26.41 35.86 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 22.6 tptp -53.47 -58.76 6.0 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.525 175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.11 -33.93 77.2 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.138 0.575 . . . . 0.0 111.442 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.442 ' SD ' HD11 ' A' ' 64' ' ' ILE . 13.5 tmm? -67.73 -47.95 67.85 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.711 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -68.98 -37.05 78.54 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 120.951 0.405 . . . . 0.0 110.626 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.7 t70 -58.74 -36.29 74.09 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.952 0.882 . . . . 0.0 108.988 -178.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -73.58 -32.33 64.08 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.894 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.442 HD11 ' SD ' ' A' ' 60' ' ' MET . 80.4 mt -75.04 -56.52 8.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -63.39 -27.25 69.18 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.195 -0.912 . . . . 0.0 112.503 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.12 -19.83 17.89 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.002 -1.094 . . . . 0.0 114.934 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.525 ' O ' ' HG3' ' A' ' 70' ' ' GLN . 78.6 mmm -114.71 -8.98 12.62 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.294 1.047 . . . . 0.0 113.673 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.27 116.03 13.33 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.806 -1.158 . . . . 0.0 111.076 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.38 -5.11 54.98 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.379 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -79.13 170.89 15.97 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 117.638 0.719 . . . . 0.0 110.921 -178.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -95.58 128.18 42.23 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.015 0.436 . . . . 0.0 110.536 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tt -134.07 106.76 7.38 Favored 'General case' 0 N--CA 1.415 -2.223 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 172.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.48 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 26.3 t70 57.36 51.25 10.19 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.999 0.904 . . . . 0.0 111.56 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.26 25.95 75.02 Favored Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.746 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -138.77 151.15 46.84 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 17.7 m120 -106.37 108.32 19.77 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.4 pt -78.98 138.48 19.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.432 -177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.1 m -101.28 115.75 31.23 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 37.7 t -116.04 131.84 67.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -151.22 171.08 17.98 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.042 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -84.08 111.2 19.1 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -73.14 -30.87 63.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 85' ' ' ARG . 34.1 tt0 70.35 128.71 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.371 1.869 . . . . 0.0 113.759 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.8 m -97.03 130.64 44.32 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.745 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 83' ' ' GLN . 6.3 mpt_? . . . . . 0 C--N 1.318 -0.781 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.078 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp 73.93 -71.78 0.13 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.231 1.412 . . . . 0.0 112.757 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.0 131.41 13.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.274 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 72.44 13.54 5.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.35 1.86 . . . . 0.0 112.509 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.0 t -104.23 107.85 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.158 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -71.4 119.43 15.53 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 31.6 m-85 -113.72 110.99 21.07 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 121.845 0.831 . . . . 0.0 111.132 174.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HD3' ' OG1' ' A' ' 53' ' ' THR . 1.6 ttp-105 -96.21 133.12 40.93 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.351 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' HB2' ' HG3' ' A' ' 60' ' ' MET . 35.7 t -112.93 143.58 43.96 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 61.5 t80 -96.16 121.22 37.7 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.0 t -117.06 113.23 42.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -118.3 147.79 18.55 Favored Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.59 57.1 1.89 Allowed Glycine 0 N--CA 1.422 -2.291 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -100.74 175.5 5.62 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.52 -175.97 2.94 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -78.91 -23.1 44.95 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.33 0.22 33.8 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 121.811 0.815 . . . . 0.0 110.12 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -69.25 117.49 10.94 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.131 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.6 p -118.55 176.63 5.16 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -62.16 -29.19 70.18 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.555 -176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.68 -45.83 64.31 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -37.89 85.37 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 123.27 0.628 . . . . 0.0 110.219 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.6 tp -70.51 -48.53 55.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.877 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.77 -56.67 24.02 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.552 -0.749 . . . . 0.0 113.084 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HA ' ' OG ' ' A' ' 27' ' ' SER . 53.6 mm-40 -66.48 -26.7 67.31 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.47 88.01 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.359 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.48 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.8 m-85 -89.4 -14.25 35.91 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.417 ' OG ' ' HA ' ' A' ' 24' ' ' GLU . 53.9 p -64.55 -24.84 67.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-O 121.817 0.817 . . . . 0.0 110.785 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -78.35 -8.67 58.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.333 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.19 -30.87 8.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.933 0.397 . . . . 0.0 110.659 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -169.77 169.19 41.93 Favored Glycine 0 N--CA 1.428 -1.89 0 C-N-CA 119.86 -1.162 . . . . 0.0 112.173 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -68.17 128.96 38.45 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.4 mm -94.95 117.06 37.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.803 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.6 mt -90.88 -26.68 19.22 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -162.29 147.36 12.57 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.652 -177.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 p -154.62 101.57 2.33 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -129.35 127.08 40.34 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.5 mm -78.09 135.85 25.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.7 mm -81.86 98.76 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.681 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -85.31 165.28 17.43 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.713 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 15.1 t70 -81.42 126.4 31.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.598 ' HB3' ' OE2' ' A' ' 42' ' ' GLU . 28.2 ttp180 -71.89 -28.01 63.23 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.051 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.598 ' OE2' ' HB3' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -87.67 -45.86 10.02 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.296 0.57 . . . . 0.0 110.449 -171.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.6 p -109.66 -10.63 14.81 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.04 -16.29 43.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.048 -0.596 . . . . 0.0 114.38 176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -67.25 155.89 37.71 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 122.626 0.37 . . . . 0.0 111.557 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.5 m -64.68 136.29 56.81 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NE ' ' HA ' ' A' ' 40' ' ' ASP . 91.2 mtt180 -86.12 0.66 53.01 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.34 57.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.644 -0.789 . . . . 0.0 114.678 172.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.0 p90 -154.19 169.95 22.38 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.703 0.751 . . . . 0.0 109.673 178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.38 37.5 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -126.45 148.64 49.62 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 122.833 0.453 . . . . 0.0 109.784 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.26 134.32 49.96 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 7' ' ' ARG . 89.4 m -109.39 129.13 55.55 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 123.042 0.537 . . . . 0.0 111.479 -176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -110.93 164.28 12.96 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.953 0.901 . . . . 0.0 111.744 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -82.2 -25.61 34.08 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.614 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.99 158.93 43.2 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.567 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 10.6 pt-20 -76.96 -35.06 57.51 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.824 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.46 ' HZ2' ' CG ' ' A' ' 62' ' ' ASP . 35.7 tttm -72.6 -34.68 67.56 Favored 'General case' 0 C--O 1.172 -3.002 0 C-N-CA 116.749 -1.981 . . . . 0.0 108.388 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.77 -34.47 65.28 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.737 0.78 . . . . 0.0 109.407 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.5 ' HG3' ' HB2' ' A' ' 8' ' ' CYS . 50.6 ttp -69.99 -43.31 71.7 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.01 -0.995 . . . . 0.0 109.716 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.419 ' HA ' HD12 ' A' ' 64' ' ' ILE . 5.9 mpt_? -67.02 -41.38 86.7 Favored 'General case' 0 C--O 1.194 -1.848 0 CA-C-O 118.904 -0.57 . . . . 0.0 112.051 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' CG ' ' HZ2' ' A' ' 58' ' ' LYS . 12.4 m-20 -58.83 -33.66 70.67 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 121.506 0.67 . . . . 0.0 110.02 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -66.55 -34.59 78.24 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.376 177.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 61' ' ' ARG . 83.1 mt -75.23 -51.65 20.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -54.26 -40.31 67.68 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.28 1.432 . . . . 0.0 112.458 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.42 -8.88 48.8 Favored Glycine 0 C--O 1.216 -0.995 0 C-N-CA 119.712 -1.232 . . . . 0.0 115.071 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 86.9 mmm -120.58 -9.19 9.44 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.588 1.194 . . . . 0.0 113.329 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.3 116.98 9.51 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 118.264 0.483 . . . . 0.0 111.95 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.54 -25.29 28.59 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.653 -0.784 . . . . 0.0 114.199 172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -81.67 -179.01 7.21 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.02 143.66 26.7 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.514 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.4 tt -147.85 110.64 4.75 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 171.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.436 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.9 t70 68.51 28.16 6.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 124.316 1.01 . . . . 0.0 111.556 175.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.48 54.55 Favored Glycine 0 C--O 1.243 0.668 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.237 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -139.42 140.74 37.45 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 115.465 -0.368 . . . . 0.0 111.361 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.77 116.09 18.89 Favored 'General case' 0 C--O 1.254 1.33 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -94.01 144.03 10.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.108 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.0 m -109.28 114.7 28.61 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 HG12 ' A' ' 64' ' ' ILE . 29.0 t -112.55 125.28 69.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.64 155.34 40.07 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -71.91 150.3 44.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.689 0.757 . . . . 0.0 111.741 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -123.62 23.35 8.86 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.267 -173.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -69.8 160.29 32.01 Favored 'General case' 0 C--O 1.257 1.456 0 C-N-CA 120.159 -0.616 . . . . 0.0 112.341 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.3 m -73.29 96.75 2.34 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.754 0.788 . . . . 0.0 111.718 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 C--N 1.304 -1.387 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.047 179.503 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.685 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.3 ttp -160.87 125.57 3.63 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 177.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.72 84.01 0.16 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.708 1.255 . . . . 0.0 110.306 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.64 3.62 54.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.053 0.93 . . . . 0.0 109.375 -176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.4 t -139.92 159.76 26.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -84.0 148.79 26.68 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HB3' ' SD ' ' A' ' 60' ' ' MET 0.42 71.0 m-85 -99.51 90.53 4.54 Favored 'General case' 0 N--CA 1.404 -2.746 0 C-N-CA 117.185 -1.806 . . . . 0.0 114.517 -177.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.7 ttm-85 -84.78 126.47 33.46 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-N 111.958 -2.383 . . . . 0.0 109.508 -174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -115.41 147.13 40.92 Favored 'General case' 0 C--N 1.274 -2.686 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 32.7 t80 -110.86 123.23 49.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.1 t -120.95 113.61 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -117.4 153.85 17.03 Favored Glycine 0 N--CA 1.422 -2.297 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.49 44.99 5.09 Favored Glycine 0 N--CA 1.427 -1.924 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 88.6 mt -90.08 175.33 7.21 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . . . -96.32 178.02 5.51 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-O 121.336 0.589 . . . . 0.0 110.215 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 29.6 p90 -78.25 -17.32 56.84 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.24 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.12 -10.75 23.72 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.1 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -67.54 118.16 10.47 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.215 0.531 . . . . 0.0 110.47 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -106.41 171.91 7.1 Favored 'General case' 0 CA--C 1.467 -2.249 0 CA-C-O 121.64 0.733 . . . . 0.0 109.394 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.87 -31.0 70.48 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.321 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -69.33 -55.11 11.38 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 1.3 m -56.12 -36.84 68.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 124.708 1.203 . . . . 0.0 112.053 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -70.79 -45.28 64.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.84 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.89 -42.65 60.04 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.482 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 12.8 pt-20 -59.9 -39.69 86.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.969 0.508 . . . . 0.0 111.842 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.42 -35.43 80.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.341 0.591 . . . . 0.0 111.483 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 76.9 m-85 -88.5 -10.08 50.21 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.2 m -65.56 -13.35 58.78 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.344 0.593 . . . . 0.0 111.314 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.89 -10.1 59.14 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.097 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.49 -44.39 3.9 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 120.75 0.31 . . . . 0.0 110.688 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.27 165.52 36.66 Favored Glycine 0 CA--C 1.488 -1.656 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -67.89 134.51 50.97 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.8 mm -86.34 116.28 28.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.6 mt -80.22 -37.55 32.91 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -158.7 145.45 17.3 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -154.98 133.72 12.09 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -149.12 132.06 16.17 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 123.392 0.432 . . . . 0.0 111.307 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 47.1 mm -73.92 137.61 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.8 mm -82.18 105.05 11.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.19 167.1 12.97 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.358 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -98.98 114.85 27.7 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -71.23 -39.57 71.59 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.849 0.833 . . . . 0.0 108.866 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -61.08 -39.2 89.01 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.173 -1.83 . . . . 0.0 112.783 -175.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 18.0 p -115.99 -15.22 11.2 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.11 0.18 80.98 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.21 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.405 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 18.2 ptt180 -87.82 178.52 6.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 120.984 0.421 . . . . 0.0 110.167 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.1 m -94.19 148.67 21.97 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.61 7.76 45.34 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 21.61 62.23 Favored Glycine 0 C--N 1.317 -0.504 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 24.6 p90 -159.03 162.37 36.68 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.877 0.838 . . . . 0.0 109.399 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -166.31 174.06 41.81 Favored Glycine 0 N--CA 1.435 -1.42 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.43 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -110.62 146.57 35.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.709 0.29 . . . . 0.0 110.933 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.8 t -130.04 118.38 43.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.3 m -100.97 123.76 45.65 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 121.441 0.639 . . . . 0.0 112.712 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.89 153.1 19.06 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.465 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -80.9 -36.39 31.22 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.194 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.68 148.61 26.37 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-O 121.738 0.78 . . . . 0.0 112.443 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' HA ' ' CD2' ' A' ' 6' ' ' TYR . 32.0 tt0 -67.22 -44.46 79.49 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.555 -1.657 . . . . 0.0 109.916 -178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.55 -40.24 70.14 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.596 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.08 -36.14 65.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 124.176 0.922 . . . . 0.0 111.641 -175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.507 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 40.8 ttp -61.55 -47.3 86.18 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.751 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 20.4 mmt180 -72.43 -35.08 68.23 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -57.71 -35.0 70.06 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.4 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -75.35 -50.08 17.09 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.036 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 60' ' ' MET . 84.7 mt -60.26 -52.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.288 -176.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 12.7 mm-40 -69.59 -16.8 63.47 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 120.701 0.286 . . . . 0.0 111.618 -174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.62 -40.01 2.63 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.489 -0.863 . . . . 0.0 113.774 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CD ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -92.91 -6.08 49.4 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -73.24 115.81 13.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.926 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.42 -9.03 48.79 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.476 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' CD ' ' HG3' ' A' ' 67' ' ' MET . 8.2 pt20 -82.53 -179.37 7.4 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 117.743 0.771 . . . . 0.0 110.927 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.35 146.22 24.2 Favored 'General case' 0 C--O 1.247 0.957 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.136 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.1 tp -148.0 108.79 4.2 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 171.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 33.8 m-20 67.67 27.85 7.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.941 1.296 . . . . 0.0 112.278 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.6 19.62 47.78 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.393 -0.908 . . . . 0.0 111.967 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -139.22 141.39 37.9 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 122.907 0.483 . . . . 0.0 110.484 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -85.12 122.95 30.06 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 121.85 0.833 . . . . 0.0 109.52 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.3 pt -99.46 145.75 9.9 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.67 -173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -108.76 115.84 30.86 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.22 129.21 65.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -142.95 172.03 13.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.135 0.493 . . . . 0.0 111.427 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HG2' ' HG3' ' A' ' 83' ' ' GLN . 37.1 tt0 -91.39 111.31 22.75 Favored 'General case' 0 N--CA 1.42 -1.951 0 C-N-CA 124.189 0.995 . . . . 0.0 108.455 -177.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -91.25 -38.84 12.42 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.392 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.504 ' HG3' ' HG2' ' A' ' 81' ' ' GLU . 82.7 mt-30 44.52 -171.04 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.649 -167.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 m -108.7 83.28 1.74 Allowed 'General case' 0 N--CA 1.414 -2.247 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 169.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.364 -174.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.238 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -169.74 4.65 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.899 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.14 30.1 0.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.38 -174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -91.45 7.94 38.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.542 0.687 . . . . 0.0 110.587 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 p -165.31 162.3 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -81.01 151.86 28.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . 0.256 17.4 m-85 -116.65 99.25 7.01 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-O 122.199 1.0 . . . . 0.0 111.916 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 12.3 tpp180 -85.36 120.19 26.56 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.418 -1.719 . . . . 0.0 108.093 -176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.725 ' SG ' ' HG2' ' A' ' 60' ' ' MET . 34.0 m -110.84 147.34 34.75 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 123.472 0.709 . . . . 0.0 109.211 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 83.8 t80 -101.7 124.68 47.75 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.87 112.26 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -110.31 165.61 12.31 Favored Glycine 0 N--CA 1.415 -2.725 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.02 6.7 58.99 Favored Glycine 0 N--CA 1.428 -1.893 0 N-CA-C 110.794 -0.923 . . . . 0.0 110.794 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 HD23 HG22 ' A' ' 77' ' ' ILE . 82.5 mt -67.34 168.79 9.96 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.602 0.715 . . . . 0.0 112.491 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.24 172.98 6.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.344 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -78.33 -24.2 46.66 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.25 -16.3 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.194 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.407 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 31.6 m -70.42 118.97 13.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -95.16 163.04 13.45 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 35' ' ' SER . 17.1 p-10 -74.23 -21.14 59.91 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -69.19 -52.17 30.64 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.138 174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.1 p -64.82 -34.45 78.39 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.984 0.421 . . . . 0.0 111.04 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 47.3 tp -62.62 -42.97 99.89 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.055 175.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.4 -50.75 36.07 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.471 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' OE1' ' HA ' ' A' ' 24' ' ' GLU . 5.5 mm-40 -61.94 -27.45 68.84 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.34 -44.41 87.85 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.505 0.669 . . . . 0.0 109.854 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 96.1 m-85 -89.22 -10.69 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 114.63 1.345 . . . . 0.0 114.63 -174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -66.59 -13.97 61.77 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.109 0.48 . . . . 0.0 112.203 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -75.47 -20.02 59.06 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.109 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -90.94 -44.26 9.47 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.239 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.44 41.73 Favored Glycine 0 N--CA 1.43 -1.728 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.743 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -67.34 125.97 27.79 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.362 0.601 . . . . 0.0 111.433 -178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.6 mm -92.29 121.12 42.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.474 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.64 -28.28 18.5 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -168.7 156.92 8.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 8.4 p -154.21 131.98 11.52 Favored 'General case' 0 C--N 1.268 -2.953 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' LYS . 31.2 mmtm -141.29 143.37 34.05 Favored 'General case' 0 CA--C 1.48 -1.713 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -105.04 120.76 56.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 104.374 -2.454 . . . . 0.0 104.374 171.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mm -96.34 128.14 47.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 4.4 p-10 -97.41 166.72 11.4 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 122.075 0.941 . . . . 0.0 113.072 -173.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -87.84 107.03 18.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.626 ' HD3' ' OE1' ' A' ' 42' ' ' GLU 0.26 0.2 OUTLIER -75.22 -7.9 55.14 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.626 ' OE1' ' HD3' ' A' ' 41' ' ' ARG . 1.5 mp0 -78.14 -47.56 17.88 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 121.461 0.648 . . . . 0.0 110.474 -176.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 45' ' ' ARG . 50.8 p -121.01 -24.35 5.61 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.03 14.24 23.22 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 119.791 -1.195 . . . . 0.0 112.44 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HG3' ' OG1' ' A' ' 43' ' ' THR . 46.6 mtt180 -82.12 -169.58 2.46 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 19.3 p -104.9 162.69 13.12 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -79.87 -6.82 58.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.38 0.537 . . . . 0.0 109.915 177.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.32 9.62 75.82 Favored Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.254 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 17.1 p90 -156.08 175.07 14.45 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.246 0.546 . . . . 0.0 111.151 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.55 30.43 Favored Glycine 0 N--CA 1.405 -3.418 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -131.72 144.71 51.17 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 38.7 t -119.62 131.98 70.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.2 m -111.81 115.19 28.63 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 120.928 0.394 . . . . 0.0 111.21 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 26' ' ' PHE . 93.7 m-85 -98.0 153.39 18.42 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.48 176.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' HB3' ' HZ3' ' A' ' 55' ' ' LYS . 4.3 ttpm? -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 174.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -114.03 136.67 52.66 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.129 -0.942 . . . . 0.0 111.346 -170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' OE1' ' HE2' ' A' ' 60' ' ' MET . 6.2 tp10 -64.86 -38.93 92.63 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.423 175.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.95 -26.95 66.2 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.149 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -81.09 -37.53 28.8 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.725 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 11.2 tmm? -55.47 -52.76 62.58 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.361 1.064 . . . . 0.0 109.734 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 62' ' ' ASP . 0.6 OUTLIER -55.17 -53.18 59.19 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.141 1.377 . . . . 0.0 110.018 -178.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 61' ' ' ARG . 1.2 m-20 -73.26 -25.32 60.65 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.744 -172.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.76 76.38 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 98.2 mt -63.78 -50.6 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.789 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.02 -45.13 86.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.77 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.41 -27.23 57.89 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 53.1 mtt -119.79 1.55 11.03 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -73.56 116.0 13.61 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.537 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.97 55.33 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.408 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -96.01 -177.5 4.03 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 117.697 0.749 . . . . 0.0 110.087 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -98.61 146.61 25.65 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.835 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.0 tp -150.78 115.39 5.19 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.1 m-20 67.22 27.77 8.3 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.038 0.935 . . . . 0.0 111.804 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.05 25.7 51.36 Favored Glycine 0 CA--C 1.5 -0.859 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -139.48 140.66 37.31 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.404 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.75 128.98 35.31 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.431 HG22 HD23 ' A' ' 13' ' ' LEU . 27.4 pt -119.19 145.78 24.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -170.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.5 m -109.41 120.25 41.94 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.574 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.3 126.73 66.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -155.2 173.58 16.42 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -54.86 139.43 40.15 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.917 2.087 . . . . 0.0 112.424 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -138.75 -0.02 1.96 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -119.88 9.23 11.24 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 118.945 -1.102 . . . . 0.0 111.823 -174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.9 t 47.2 75.15 0.13 Allowed 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.963 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.253 170.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.449 ' HA2' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.463 0.471 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB2' ' CB ' ' A' ' 56' ' ' ASP . 25.2 mmt -134.84 -7.85 2.4 Favored 'General case' 0 C--O 1.246 0.918 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.86 -45.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.313 0.578 . . . . 0.0 110.961 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' OE2' ' HA2' ' A' ' 0' ' ' GLY 0.341 28.8 mm-40 87.51 75.82 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 126.859 2.064 . . . . 0.0 113.683 176.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.532 HG22 ' H ' ' A' ' 5' ' ' GLU . 12.1 p -171.03 -166.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 104.089 -2.559 . . . . 0.0 104.089 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.532 ' H ' HG22 ' A' ' 4' ' ' VAL . 0.7 OUTLIER -116.69 148.02 41.43 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 119.473 1.033 . . . . 0.0 109.701 172.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 16.3 m-85 -126.8 154.1 44.72 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.072 0.463 . . . . 0.0 110.815 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' HB2' ' NH1' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -131.88 133.79 45.0 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -171.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.2 t -115.64 144.82 43.36 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -108.7 122.62 47.52 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.59 113.66 40.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.35 161.42 14.63 Favored Glycine 0 N--CA 1.425 -2.098 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.85 44.32 9.26 Favored Glycine 0 N--CA 1.431 -1.666 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.446 HD23 ' CG2' ' A' ' 77' ' ' ILE . 90.3 mt -94.41 175.42 6.69 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.705 0.802 . . . . 0.0 108.887 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -86.2 163.64 17.68 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -75.0 -6.96 52.16 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.647 0.26 . . . . 0.0 110.868 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -113.44 1.76 15.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 97.9 m -65.15 124.36 21.93 Favored 'General case' 0 C--O 1.253 1.242 0 CA-C-O 121.112 0.482 . . . . 0.0 109.846 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -103.23 165.03 11.27 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.266 -176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.544 ' OD2' ' HE3' ' A' ' 36' ' ' LYS . 0.8 OUTLIER -66.77 -35.79 80.92 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.105 176.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -62.01 -55.57 27.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.513 174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 40.2 p -58.71 -31.38 68.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.262 0.554 . . . . 0.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.428 HD22 HD13 ' A' ' 37' ' ' ILE . 26.9 tp -67.51 -55.97 11.39 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.22 -47.6 86.68 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.891 -175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -57.62 -40.53 79.37 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.869 0.467 . . . . 0.0 111.393 -177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.2 -50.43 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -72.21 -17.67 61.9 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.9 m -67.33 -15.2 63.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.06 0.457 . . . . 0.0 111.446 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -80.99 -17.94 48.63 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.814 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 44.2 m-85 -114.66 -44.39 3.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.29 0.567 . . . . 0.0 111.797 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -131.77 153.24 20.39 Favored Glycine 0 N--CA 1.416 -2.65 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.777 -174.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 55' ' ' LYS . 32.6 mt-10 -64.91 116.78 6.72 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 124.364 1.066 . . . . 0.0 108.838 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.9 mm -96.15 131.83 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 122.51 0.324 . . . . 0.0 110.203 -177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.4 mt -105.91 -29.42 9.99 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -165.1 150.11 9.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.344 -177.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.2 p -154.53 101.76 2.36 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.544 ' HE3' ' OD2' ' A' ' 19' ' ' ASP . 4.4 mmmm -125.41 128.92 48.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.428 HD13 HD22 ' A' ' 22' ' ' LEU . 42.8 mm -76.62 143.12 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 170.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -80.46 113.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.123 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -80.24 158.25 26.27 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.421 -174.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 16.1 t70 -86.17 119.58 26.62 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.44 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.15 -30.33 66.33 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.797 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -79.77 -40.02 29.63 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.496 ' OG1' ' HD3' ' A' ' 45' ' ' ARG . 22.8 p -121.25 -11.42 8.81 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.66 12.0 73.14 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 119.921 -1.133 . . . . 0.0 112.085 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 16.9 mtp-105 -88.45 -155.27 0.32 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 123.997 0.919 . . . . 0.0 109.631 179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.427 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 31.4 m -110.64 146.52 36.03 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 21.8 mmm180 -76.78 -7.8 56.1 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 117.958 0.344 . . . . 0.0 111.378 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.38 49.51 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.37 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -158.56 166.36 32.3 Favored 'General case' 0 C--O 1.249 1.04 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.34 175.31 37.95 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -122.05 144.78 48.7 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.52 130.01 73.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 73.7 m -95.63 113.14 24.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -98.6 153.07 18.94 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.751 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 31' ' ' GLU . 25.1 tptp -66.54 -50.09 64.34 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.273 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.517 ' OD2' ' HG3' ' A' ' 55' ' ' LYS . 36.5 m-20 -141.03 176.49 8.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 119.485 -0.886 . . . . 0.0 112.027 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -66.27 -47.73 72.73 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -173.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -62.68 -41.54 99.15 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.924 0.392 . . . . 0.0 110.134 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.26 70.54 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.738 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.422 ' O ' HG13 ' A' ' 64' ' ' ILE . 38.1 ttp -78.19 -55.51 5.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.021 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.41 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 10.1 mmm180 -56.66 -52.92 63.04 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.506 -175.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 28.0 t70 -55.44 -38.13 68.59 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.533 0.683 . . . . 0.0 111.245 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.15 -38.72 75.55 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.476 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 60' ' ' MET . 96.8 mt -68.21 -56.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.645 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 37.7 mt-10 -74.1 -16.78 61.01 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.058 -173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 -28.68 13.32 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.19 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 47.6 mtt -109.8 1.27 19.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.84 116.38 13.28 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.934 -0.707 . . . . 0.0 110.177 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.54 -11.07 35.86 Favored Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.394 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.4 pt20 -83.0 -177.81 6.9 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.774 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.55 145.38 25.26 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.914 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 77' ' ' ILE . 57.8 tp -147.98 110.18 4.59 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 171.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 67.63 28.54 7.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 124.776 1.23 . . . . 0.0 112.209 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.5 18.74 43.98 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.537 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -139.73 141.75 36.86 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 122.586 0.354 . . . . 0.0 111.1 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -82.86 120.21 25.37 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.993 0.902 . . . . 0.0 108.625 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 72' ' ' LEU . 36.0 pt -102.86 149.63 7.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 114.76 -1.109 . . . . 0.0 113.869 -169.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.2 m -103.76 115.41 30.43 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.0 t -110.11 115.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -135.39 161.69 34.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.914 0.864 . . . . 0.0 112.379 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' CG ' ' HG3' ' A' ' 83' ' ' GLN . 37.5 tt0 -76.66 128.1 34.05 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.243 -176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -109.46 -23.71 11.38 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 80.6 mt-30 51.5 -167.22 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.719 1.207 . . . . 0.0 111.898 -172.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -81.79 30.31 0.37 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 83' ' ' GLN . 19.9 mtm180 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.908 -176.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.252 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt -164.24 -58.4 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 100.29 3.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 92.48 7.55 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.093 -172.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 5' ' ' GLU . 11.3 p -160.15 176.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' H ' HG22 ' A' ' 4' ' ' VAL . 4.4 pt-20 -78.6 125.64 29.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.247 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 57' ' ' GLU . 24.1 m-85 -102.2 94.45 5.74 Favored 'General case' 0 N--CA 1.399 -2.988 0 CA-C-O 122.537 1.16 . . . . 0.0 110.984 173.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.604 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 18.5 tpp180 -84.93 126.97 33.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 112.733 -2.03 . . . . 0.0 107.564 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.6 t -118.77 146.97 44.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -95.31 124.32 39.28 Favored 'General case' 0 C--O 1.244 0.787 0 O-C-N 123.357 0.411 . . . . 0.0 110.14 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -123.65 114.44 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -127.74 158.99 21.52 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.1 62.15 1.94 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD1' HD12 ' A' ' 37' ' ' ILE . 75.7 mt -100.69 175.8 5.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -98.48 -163.44 1.04 Allowed 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 121.139 0.495 . . . . 0.0 111.716 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.7 t90 -77.72 -33.4 53.03 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.557 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.44 8.68 16.6 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.137 0.494 . . . . 0.0 111.562 -172.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 m -67.43 118.75 11.19 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.494 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.9 p -115.53 173.42 6.54 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.191 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -22.67 59.39 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.136 0.493 . . . . 0.0 110.639 176.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -62.92 -47.55 82.78 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.469 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.5 p -78.01 -28.09 49.08 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.335 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 tp -69.27 -42.06 76.03 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.91 -57.67 18.49 Favored Glycine 0 C--O 1.217 -0.938 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.686 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -62.49 -28.32 69.74 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.64 -44.36 94.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.346 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 74.9 m-85 -88.67 -14.88 36.3 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.8 t -61.36 -30.1 70.32 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 123.956 0.902 . . . . 0.0 109.995 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -74.23 -11.01 60.16 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.824 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -107.02 -41.01 5.29 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -160.68 171.58 36.84 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 118.592 -1.766 . . . . 0.0 113.874 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -69.41 117.56 11.19 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 124.078 0.951 . . . . 0.0 109.296 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 59.7 mt -101.03 128.9 52.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.112 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 55' ' ' LYS . 80.6 mt -93.5 -32.38 14.2 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.621 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -162.46 151.02 14.72 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.765 -175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -154.61 107.95 2.87 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 17.1 mmmt -136.4 134.77 38.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -176.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 13' ' ' LEU . 51.1 mm -84.0 143.8 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.641 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 173.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.16 107.65 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.957 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -80.87 156.92 25.84 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.116 -176.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -91.09 127.99 36.74 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 113.867 -1.515 . . . . 0.0 109.966 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HB2' ' OE1' ' A' ' 42' ' ' GLU . 36.7 mtm180 -73.16 -32.74 65.05 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 41' ' ' ARG . 2.4 mp0 -73.19 -59.05 2.89 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.264 -172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.2 p -102.01 -8.1 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.6 11.83 83.61 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.599 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 38.8 mtp-105 -96.89 -159.11 0.71 Allowed 'General case' 0 C--N 1.314 -0.974 0 O-C-N 122.608 -0.348 . . . . 0.0 110.846 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB3' HG21 ' A' ' 37' ' ' ILE . 18.2 m -93.96 145.69 24.46 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.1 mtp85 -88.15 7.03 33.68 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.628 0.649 . . . . 0.0 112.249 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.24 -1.04 58.83 Favored Glycine 0 C--O 1.24 0.503 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.663 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -151.09 165.84 32.61 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.52 -178.53 34.58 Favored Glycine 0 N--CA 1.427 -1.962 0 N-CA-C 111.289 -0.725 . . . . 0.0 111.289 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -128.85 146.22 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.012 0.434 . . . . 0.0 110.65 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.4 p -122.38 138.65 51.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -115.77 121.19 41.72 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.191 0.519 . . . . 0.0 111.908 -173.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -107.82 174.44 5.88 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.203 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.79 -28.83 9.43 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.463 0.649 . . . . 0.0 109.32 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -111.22 137.03 49.45 Favored 'General case' 0 CA--C 1.492 -1.272 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 11.0 pt-20 -75.3 -30.3 60.32 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.2 -46.81 88.92 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.541 ' HA ' ' OD2' ' A' ' 62' ' ' ASP . . . -63.77 -25.93 68.41 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.086 0.866 . . . . 0.0 111.02 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 64' ' ' ILE . 58.4 ttp -68.63 -38.27 80.4 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.746 177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -69.95 -39.81 75.82 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.379 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.541 ' OD2' ' HA ' ' A' ' 59' ' ' ALA . 10.0 m-20 -53.87 -38.62 64.91 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.833 0.825 . . . . 0.0 109.0 175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -70.23 -41.13 73.97 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.846 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 60' ' ' MET . 83.1 mt -66.68 -56.07 15.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.148 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -68.13 -25.08 65.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.363 -175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -97.77 -5.03 57.76 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.354 -0.927 . . . . 0.0 114.32 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 9.7 mmt -120.87 -24.89 5.52 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -67.47 116.47 8.25 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.133 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.98 -24.76 15.69 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.472 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -88.27 173.77 8.58 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.796 -0.761 . . . . 0.0 112.581 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -88.92 141.13 28.75 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.333 0.587 . . . . 0.0 112.002 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 tp -146.38 110.14 4.89 Favored 'General case' 0 N--CA 1.41 -2.453 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 170.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.1 t70 68.48 27.32 6.32 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.48 1.112 . . . . 0.0 111.54 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.26 15.73 52.59 Favored Glycine 0 C--O 1.243 0.658 0 C-N-CA 120.165 -1.017 . . . . 0.0 112.782 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -139.19 140.56 37.84 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 120.747 0.308 . . . . 0.0 110.92 178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -78.54 108.45 11.93 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 173.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -76.98 141.41 15.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.569 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.3 m -109.1 114.55 28.38 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.3 t -116.23 132.9 64.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 -175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.38 172.15 13.59 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.529 0.68 . . . . 0.0 112.134 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 85' ' ' ARG . 9.3 tp10 -73.29 133.27 43.85 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.895 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -108.4 -14.41 14.67 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.09 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -70.64 -62.13 1.51 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.118 0.485 . . . . 0.0 109.809 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 24.2 m -103.58 -17.51 15.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.093 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 81' ' ' GLU . 35.1 mtm-85 . . . . . 0 N--CA 1.473 0.684 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.861 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.572 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -107.79 -64.84 1.17 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.79 72.42 0.13 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.19 13.55 3.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.09 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.4 t -81.13 137.93 20.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.649 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.0 137.72 53.92 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-O 121.77 0.795 . . . . 0.0 112.059 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -122.81 115.59 22.26 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 171.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.475 ' NH1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -85.38 126.77 34.03 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.837 -178.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.2 t -113.44 141.21 47.37 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -100.78 121.19 41.26 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.3 t -119.16 113.51 41.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.16 162.05 15.02 Favored Glycine 0 C--N 1.295 -1.73 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 87.23 41.0 6.74 Favored Glycine 0 CA--C 1.495 -1.208 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.4 mt -88.5 175.36 7.62 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.548 0.69 . . . . 0.0 111.939 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.575 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -114.41 -168.64 1.4 Allowed 'General case' 0 N--CA 1.421 -1.922 0 CA-C-N 114.966 -1.015 . . . . 0.0 113.232 -170.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -78.49 -45.78 21.21 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.33 3.63 27.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.316 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.0 m -80.76 117.0 21.05 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.127 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -116.61 175.97 5.32 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -71.08 -20.34 62.36 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -65.87 -53.64 37.06 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 173.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.562 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 3.1 m -59.64 -33.67 71.82 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.48 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.7 tp -66.64 -47.8 71.44 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.86 -44.97 66.13 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.361 -0.836 . . . . 0.0 113.01 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.0 pt-20 -63.86 -28.88 70.15 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.169 0.485 . . . . 0.0 111.161 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.85 -56.27 4.64 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.869 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.39 -16.01 61.35 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 -172.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 10.7 p -68.67 -13.81 62.61 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.54 0.686 . . . . 0.0 111.303 177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -70.06 -25.51 63.58 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -114.14 -38.84 4.04 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -135.36 148.47 19.61 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 118.754 -1.689 . . . . 0.0 113.212 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -68.17 137.54 54.95 Favored 'General case' 0 C--O 1.257 1.467 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.1 117.5 50.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.185 -171.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.467 HD21 ' HG3' ' A' ' 55' ' ' LYS . 75.9 mt -91.94 -26.63 18.33 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.05 148.81 3.47 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.998 1.319 . . . . 0.0 108.767 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 32.2 p -154.93 109.72 3.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -133.9 139.4 46.15 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' H ' ' HB3' ' A' ' 19' ' ' ASP . 47.3 mm -88.38 138.35 19.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.7 mm -87.46 114.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -80.93 149.96 29.2 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.224 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -84.38 119.57 25.26 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -71.3 -30.34 66.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 120.745 0.307 . . . . 0.0 111.328 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -77.02 -40.32 46.96 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.448 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -111.53 -18.83 12.74 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.09 8.7 78.3 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.956 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 46' ' ' SER . 26.5 ptt-85 -96.9 -178.24 4.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 14.4 m -76.81 139.03 40.21 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 170.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -74.84 -2.71 27.95 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.3 0.955 . . . . 0.0 111.576 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 7.16 55.98 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.145 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -155.87 169.34 24.63 Favored 'General case' 0 C--O 1.247 0.971 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.69 178.76 34.76 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -125.93 144.88 50.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.021 0.439 . . . . 0.0 110.524 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -123.97 139.61 49.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 m -107.71 111.5 23.73 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -95.37 156.66 16.23 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.113 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' HG3' HD21 ' A' ' 33' ' ' LEU . 2.3 ttpm? -74.82 -12.57 60.42 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.291 -175.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -168.12 -179.16 3.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 32.8 tt0 -77.46 -39.5 46.39 Favored 'General case' 0 N--CA 1.429 -1.512 0 O-C-N 123.917 0.761 . . . . 0.0 111.945 -176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.2 tptp -72.4 -37.31 68.73 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 119.372 -0.931 . . . . 0.0 109.714 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.46 -33.0 69.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.712 0.767 . . . . 0.0 110.029 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 13.7 tmm? -76.45 -40.5 50.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.823 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.9 mmt180 -60.47 -51.75 68.14 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.083 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 10.6 m-20 -57.88 -30.7 66.07 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.504 0.722 . . . . 0.0 112.437 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.97 -33.75 70.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.436 0.636 . . . . 0.0 109.669 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.0 mt -75.2 -52.24 19.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.817 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -59.49 -39.32 83.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.173 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -95.91 -19.26 29.46 Favored Glycine 0 N--CA 1.437 -1.3 0 C-N-CA 119.904 -1.141 . . . . 0.0 114.578 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 55.2 mtt -120.25 -5.15 9.93 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' ' 78' ' ' THR . 2.4 t-20 -73.56 116.19 13.84 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 117.515 -1.674 . . . . 0.0 110.667 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.45 -15.4 27.32 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.215 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 67' ' ' MET . 10.6 pt20 -75.03 169.03 18.82 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-N 117.417 0.609 . . . . 0.0 110.733 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 13.2 t70 -92.35 141.03 29.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.867 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.2 tp -142.3 106.82 4.82 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.575 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 23.6 t70 52.11 52.74 13.74 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.996 1.318 . . . . 0.0 112.314 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.59 23.58 67.16 Favored Glycine 0 C--O 1.241 0.535 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.746 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 10.1 mpt_? -138.04 156.45 47.79 Favored 'General case' 0 CA--C 1.466 -2.255 0 CA-C-O 121.261 0.553 . . . . 0.0 110.889 177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -102.83 108.15 19.27 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -76.85 134.79 28.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 122.218 1.008 . . . . 0.0 112.996 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.55 ' HA ' ' ND2' ' A' ' 68' ' ' ASN . 34.3 m -103.54 114.68 29.14 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 114.593 -1.185 . . . . 0.0 107.899 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.4 t -112.88 119.27 60.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.54 166.48 24.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.103 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.477 ' HG2' ' H ' ' A' ' 83' ' ' GLN . 59.3 tt0 -76.0 124.52 27.51 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.75 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.36 19.62 5.05 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.147 0.499 . . . . 0.0 111.657 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 8.9 tt0 -94.2 150.21 20.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 174.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.5 m -53.34 108.9 0.38 Allowed 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.493 0.663 . . . . 0.0 112.636 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.1 177.876 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.112 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LYS . 93.8 mtp -138.38 21.64 2.75 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.48 -15.74 12.54 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.829 0.823 . . . . 0.0 109.492 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -92.71 0.47 57.43 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.118 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.25 126.11 72.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.715 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.5 OUTLIER -101.23 146.21 27.83 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.684 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.81 ' CE2' ' HG2' ' A' ' 57' ' ' GLU 0.258 25.9 m-85 -125.89 90.71 3.25 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.805 1.288 . . . . 0.0 111.063 171.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.42 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 38.0 ttp-105 -85.32 129.96 34.7 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.226 -172.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -122.73 135.21 54.5 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 51.8 t80 -97.66 135.16 39.87 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -177.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.9 t -127.78 113.36 30.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 49' ' ' PHE . . . -118.59 154.2 16.63 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.56 55.45 2.57 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.6 mt -105.51 175.75 5.39 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.106 0.962 . . . . 0.0 108.552 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.492 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -100.0 -171.36 2.03 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.457 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -78.57 -33.11 47.91 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.66 -172.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.21 -2.67 39.19 Favored 'General case' 0 C--O 1.255 1.362 0 CA-C-O 121.081 0.467 . . . . 0.0 111.22 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.7 m -63.58 117.91 7.45 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.61 160.53 16.19 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.139 -177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 35' ' ' SER . 12.0 p-10 -69.4 -36.98 77.28 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.964 -173.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -59.7 -47.42 85.71 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.664 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.3 p -74.07 -33.06 63.53 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.555 -177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.91 -36.06 82.72 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.83 -57.39 12.41 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.779 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -59.13 -28.3 66.42 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.402 0.62 . . . . 0.0 110.09 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.44 -11.23 43.67 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 49.0 m -61.16 -13.72 19.89 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -71.17 -26.1 62.82 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.133 0.492 . . . . 0.0 110.289 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -89.47 -40.1 12.91 Favored 'General case' 0 C--O 1.25 1.112 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.808 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 27' ' ' SER . . . -176.37 162.67 31.5 Favored Glycine 0 CA--C 1.499 -0.936 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 176.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.35 135.34 55.18 Favored 'General case' 0 C--O 1.254 1.309 0 CA-C-N 117.908 0.854 . . . . 0.0 111.387 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.6 mm -87.1 130.83 36.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.891 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' A' ' 55' ' ' LYS . 61.1 mt -83.87 -37.02 22.97 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -169.97 142.5 2.37 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 3.4 p -130.1 146.9 51.79 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' O ' ' HA3' ' A' ' 50' ' ' GLY . 29.4 mmtm -138.13 140.99 40.16 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.8 mm -106.03 126.05 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 168.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.9 mm -89.99 116.43 31.36 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.27 -176.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -80.48 161.31 24.93 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 114.21 -1.359 . . . . 0.0 112.423 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 42' ' ' GLU . 35.1 t0 -81.99 132.87 35.26 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.055 -171.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' ARG . 52.1 mmt-85 -74.36 -27.05 60.49 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.946 -1.024 . . . . 0.0 111.326 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.523 ' HB2' ' OD2' ' A' ' 40' ' ' ASP . 48.4 mt-10 -73.58 -61.65 1.76 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.665 0.603 . . . . 0.0 110.751 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.0 p -118.39 -13.14 9.79 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.91 0.48 66.21 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.669 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -70.75 176.61 4.09 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.631 0.772 . . . . 0.0 111.025 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.1 m -78.4 130.9 36.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 52.5 mtp85 -87.31 2.01 51.53 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 119.447 -0.901 . . . . 0.0 112.166 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.4 34.56 40.06 Favored Glycine 0 N--CA 1.438 -1.206 0 CA-C-N 115.773 -0.648 . . . . 0.0 113.874 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.497 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 16.3 p90 -166.64 169.57 13.45 Favored 'General case' 0 C--O 1.249 1.045 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . 178.57 -149.55 9.06 Favored Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -158.37 166.05 33.22 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.3 143.12 41.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -109.53 116.27 31.47 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.618 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' A' ' 60' ' ' MET . 94.8 m-85 -99.82 171.31 7.96 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 1' ' ' MET . 55.6 pttt -107.0 -17.36 14.2 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 122.106 0.955 . . . . 0.0 108.714 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.508 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 7.0 t0 -111.63 140.37 46.31 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.852 -170.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.81 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 9.2 mt-10 -73.21 -37.45 66.44 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.823 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.508 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 14.2 ttpp -63.51 -59.76 4.23 Favored 'General case' 0 C--O 1.202 -1.411 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.74 29.57 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 124.951 1.301 . . . . 0.0 112.757 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.573 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . 32.7 ttp -60.94 -56.03 25.88 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 121.21 0.529 . . . . 0.0 110.55 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.411 ' HA ' HD12 ' A' ' 64' ' ' ILE . 15.7 tpt180 -70.2 -36.65 74.75 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.679 -174.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 12.0 t0 -55.15 -46.68 75.73 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 126.2 1.8 . . . . 0.0 108.357 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.75 81.54 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.35 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 60' ' ' MET . 76.5 mt -69.66 -56.51 11.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.925 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -78.39 -16.35 57.73 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.62 -32.82 5.29 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 120.126 -1.035 . . . . 0.0 114.702 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 1.6 tpt -102.69 -10.06 19.52 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 118.156 0.978 . . . . 0.0 112.436 -172.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -70.34 118.69 13.47 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.858 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.46 -2.13 27.89 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.91 -1.138 . . . . 0.0 112.998 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -82.76 176.12 9.58 Favored 'General case' 0 C--O 1.252 1.199 0 C-N-CA 119.776 -0.769 . . . . 0.0 109.572 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -103.3 138.14 40.47 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 171.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -143.43 114.72 7.94 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.9 t70 67.95 27.89 7.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.532 1.133 . . . . 0.0 111.037 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.39 21.47 51.48 Favored Glycine 0 CA--C 1.5 -0.895 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.503 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -139.03 137.92 36.73 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-O 121.296 0.569 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -81.19 114.51 20.06 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.4 pt -98.15 149.91 5.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.023 -172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.2 m -114.05 117.76 32.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.189 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.5 t -109.67 123.38 65.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -137.13 172.22 13.32 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.353 0.597 . . . . 0.0 112.142 -177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -87.1 122.83 31.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.045 -174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -100.82 25.52 7.85 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.628 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -73.52 89.78 1.71 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.8 m -144.95 106.18 4.2 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 C--N 1.311 -1.088 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -177.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.418 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.497 -1.055 0 N-CA-C 110.266 -1.133 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 ttp -164.92 72.99 0.21 Allowed 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.28 79.3 0.24 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.446 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 8.6 mp0 -87.42 -27.47 22.72 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 123.004 1.383 . . . . 0.0 108.053 176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 t -146.02 170.24 5.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.415 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 136.04 38.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.953 174.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' ' 57' ' ' GLU 0.258 35.1 m-85 -101.16 90.23 4.07 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-O 123.256 1.503 . . . . 0.0 112.019 -174.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 ttp85 -93.13 134.05 35.68 Favored 'General case' 0 N--CA 1.4 -2.957 0 CA-C-N 112.481 -2.145 . . . . 0.0 112.797 -173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.6 t -111.8 144.34 41.26 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.758 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' HE1' ' CD2' ' A' ' 49' ' ' PHE . 40.0 t80 -102.57 124.62 48.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.4 t -126.07 113.58 34.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -118.73 166.37 12.98 Favored Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.42 41.06 8.62 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD13 HD12 ' A' ' 37' ' ' ILE . 73.8 mt -88.49 175.74 7.46 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 123.937 0.895 . . . . 0.0 109.979 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.2 170.57 8.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -77.79 -6.82 55.38 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.037 0.446 . . . . 0.0 110.674 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.8 -1.13 18.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.716 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 52.6 m -72.53 122.49 21.42 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.906 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -100.84 161.16 13.79 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 35' ' ' SER . 20.1 p-10 -74.36 -22.2 59.32 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -64.42 -59.55 4.21 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.326 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.1 p -62.95 -37.49 87.26 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.076 0.465 . . . . 0.0 111.712 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -60.01 -40.74 90.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.163 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.13 -45.84 53.97 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.488 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.9 -42.7 85.23 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.217 0.607 . . . . 0.0 112.357 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.73 83.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.531 . . . . 0.0 111.46 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.402 ' CD1' ' HB1' ' A' ' 63' ' ' ALA . 65.1 m-85 -88.63 -14.22 37.97 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.098 0.406 . . . . 0.0 112.098 -178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 30.1 t -71.71 -13.65 61.79 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.026 0.441 . . . . 0.0 110.071 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -75.9 -11.93 60.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.075 176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -114.11 -43.44 3.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.02 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -146.61 165.76 28.32 Favored Glycine 0 N--CA 1.427 -1.954 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.456 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -75.74 120.7 21.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 121.41 0.624 . . . . 0.0 109.694 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.7 mm -90.82 135.46 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.049 -176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.5 mt -89.04 -40.26 13.09 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 36' ' ' LYS . 19.7 t70 -170.65 147.26 2.82 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 175.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 5.3 p -131.36 140.89 49.8 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 176.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 34' ' ' ASP . 30.3 mmtm -139.61 147.86 41.67 Favored 'General case' 0 CA--C 1.483 -1.619 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' LEU . 41.2 mm -101.23 117.71 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 168.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.06 99.43 7.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-O 122.462 1.125 . . . . 0.0 109.702 -177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 46' ' ' SER . 91.5 m-20 -83.15 167.74 17.48 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.326 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -98.29 108.33 21.0 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -71.51 -33.55 69.31 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.899 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.15 -45.56 80.56 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.821 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.9 p -104.07 -5.07 22.45 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.75 21.17 77.28 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.25 -0.5 . . . . 0.0 111.962 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -108.86 -164.94 0.98 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 32.3 t -117.35 158.57 24.18 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -102.3 3.87 38.54 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.211 0.529 . . . . 0.0 110.989 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 21.06 76.76 Favored Glycine 0 C--O 1.242 0.596 0 CA-C-N 115.3 -0.864 . . . . 0.0 115.005 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CD2' ' HE1' ' A' ' 9' ' ' PHE . 29.0 p90 -151.52 169.21 22.63 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 36' ' ' LYS . . . -162.91 -168.62 25.11 Favored Glycine 0 N--CA 1.412 -2.959 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.027 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -134.73 148.78 50.36 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.47 114.92 38.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.1 m -93.79 115.56 27.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.117 0.484 . . . . 0.0 111.253 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -98.39 160.73 14.09 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.445 178.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -86.27 -39.8 16.18 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.561 0.696 . . . . 0.0 109.219 171.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -104.9 137.71 42.26 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.039 -171.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -80.53 -37.35 31.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 -175.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -61.57 -46.79 88.4 Favored 'General case' 0 C--O 1.213 -0.816 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.322 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.448 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -61.57 -33.13 73.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.831 0.707 . . . . 0.0 110.698 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.453 ' O ' HG13 ' A' ' 64' ' ' ILE . 53.4 ttp -62.7 -44.8 95.3 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.048 174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' HB3' ' OE1' ' A' ' 65' ' ' GLU . 11.7 mmm180 -63.07 -46.3 88.09 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.974 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -55.83 -35.31 66.24 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.649 0.738 . . . . 0.0 109.656 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' HB1' ' CD1' ' A' ' 26' ' ' PHE . . . -72.78 -47.79 43.66 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.529 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 87.5 mt -64.95 -55.97 18.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.868 -177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 61' ' ' ARG . 38.4 mt-10 -79.06 -16.21 57.12 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.329 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.92 -32.05 5.17 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.208 -0.996 . . . . 0.0 114.095 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.57 ' O ' ' HG2' ' A' ' 70' ' ' GLN . 90.0 mmm -107.63 14.71 25.4 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.689 0.744 . . . . 0.0 112.08 -174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -71.84 116.56 12.37 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.55 -4.31 54.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.358 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 67' ' ' MET . 0.8 OUTLIER -66.94 161.52 23.94 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 120.961 0.41 . . . . 0.0 110.922 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -87.66 132.88 33.94 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 tt -141.77 108.45 5.36 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 72.6 m-20 67.36 30.75 6.82 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.745 1.218 . . . . 0.0 112.229 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.62 17.06 55.71 Favored Glycine 0 C--N 1.337 0.603 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.61 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -140.12 140.45 36.01 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 19.8 m120 -79.67 110.21 14.79 Favored 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.7 pp -95.19 153.09 3.57 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-O 121.637 0.732 . . . . 0.0 112.847 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.9 m -111.43 118.11 34.91 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.085 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 64' ' ' ILE . 15.5 t -108.95 128.61 64.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.26 170.05 16.74 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.375 -0.231 . . . . 0.0 110.375 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -90.22 129.99 36.41 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.83 0.348 . . . . 0.0 111.452 -172.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -116.84 34.84 4.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.1 107.18 0.05 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 126.203 1.801 . . . . 0.0 114.777 -175.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -64.86 107.09 1.37 Allowed 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.358 -1.292 . . . . 0.0 111.915 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.946 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.469 176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.578 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.4 ttm -149.59 23.84 0.89 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.98 89.11 0.7 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -103.22 82.12 2.03 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.55 155.49 38.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.495 -172.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.53 103.14 1.98 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 121.773 0.797 . . . . 0.0 111.341 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.513 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 7.1 m-85 -96.58 96.3 8.56 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-O 122.32 1.057 . . . . 0.0 109.412 174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -86.9 126.32 34.6 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 113.54 -1.664 . . . . 0.0 109.517 -174.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.0 t -111.1 142.63 43.01 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 82' ' ' ALA . 38.8 t80 -101.68 121.98 43.05 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -120.55 113.6 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.46 157.25 16.35 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.65 49.55 4.31 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 HD22 HG21 ' A' ' 17' ' ' THR . 86.2 mt -92.32 175.25 6.91 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.74 172.33 8.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -74.98 -20.83 59.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.0 -5.08 45.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.244 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HA ' ' OD2' ' A' ' 73' ' ' ASP . 88.7 m -70.01 118.74 13.23 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 121.379 0.609 . . . . 0.0 110.304 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.7 p -103.98 159.35 15.74 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -20.01 63.35 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.865 175.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 10.1 tt0 -66.05 -59.28 3.95 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -60.39 -35.44 75.74 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-O 121.346 0.593 . . . . 0.0 111.141 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' HD2' ' A' ' 26' ' ' PHE . 34.8 tp -59.51 -53.24 60.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.108 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.36 -45.43 95.04 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.633 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 40.7 mt-10 -54.79 -49.17 71.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.57 0.748 . . . . 0.0 110.909 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.72 92.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.672 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 96.5 m-85 -80.74 -13.67 58.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 60.9 m -67.95 -18.46 64.76 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.459 0.647 . . . . 0.0 110.448 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -76.59 -19.74 57.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.215 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' HD2' ' OD1' ' A' ' 62' ' ' ASP . 89.6 m-85 -98.12 -33.31 11.2 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.956 -176.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 59' ' ' ALA . . . 178.7 -174.03 46.26 Favored Glycine 0 N--CA 1.436 -1.337 0 C-N-CA 119.31 -1.424 . . . . 0.0 114.317 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 34.3 mt-10 -66.02 123.18 19.16 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.837 1.255 . . . . 0.0 111.184 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.21 135.19 33.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.0 mt -98.88 -40.71 7.96 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.79 146.74 13.13 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 28.8 p -154.36 114.41 3.85 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -139.31 145.64 39.35 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.5 mm -82.12 135.09 25.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.0 mm -92.12 116.38 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.69 0 CA-C-O 121.607 0.718 . . . . 0.0 109.607 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -95.7 160.45 14.48 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.099 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -96.95 108.3 20.99 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.64 -6.94 47.73 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -94.31 -49.81 5.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.8 p -88.45 -15.67 34.81 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.07 -5.79 82.95 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 121.001 -0.619 . . . . 0.0 114.107 175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' H ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -111.92 166.7 10.98 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.9 m -64.1 140.02 58.83 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 123.857 0.863 . . . . 0.0 111.137 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -82.87 -9.96 59.07 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.33 17.75 51.85 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.76 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.38 165.69 33.32 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.58 175.07 35.0 Favored Glycine 0 N--CA 1.423 -2.182 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' SER . 93.8 m-85 -117.67 142.0 47.74 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.07 114.67 41.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -101.21 126.8 47.97 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-O 121.131 0.491 . . . . 0.0 111.477 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 98.8 m-85 -106.79 160.89 15.15 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.961 177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 31' ' ' GLU . 13.8 ttpt -104.64 -7.68 19.46 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -125.2 140.27 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.683 -173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 9.0 tp10 -60.05 -48.22 82.6 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 124.064 0.946 . . . . 0.0 111.17 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' ASP . 9.9 ttpp -63.37 -45.88 89.06 Favored 'General case' 0 C--O 1.201 -1.479 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 30' ' ' GLY . . . -49.03 -46.44 44.16 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.374 1.07 . . . . 0.0 111.936 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 52.3 ttp -70.33 -45.59 65.91 Favored 'General case' 0 C--O 1.214 -0.764 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.371 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 29.8 mmt180 -61.87 -45.81 92.13 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 121.722 0.772 . . . . 0.0 110.103 -178.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 58' ' ' LYS . 2.9 t70 -56.92 -36.05 69.75 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 125.105 1.362 . . . . 0.0 108.711 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.8 -40.2 41.38 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.364 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 60' ' ' MET . 71.4 mt -72.05 -56.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.1 -17.05 63.81 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.199 -177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -100.61 -42.66 2.46 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.441 -0.885 . . . . 0.0 114.316 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 81.6 mmm -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -172.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -72.66 116.37 13.05 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.591 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.27 -22.56 20.22 Favored Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.703 -0.761 . . . . 0.0 113.113 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 pt20 -85.46 178.72 7.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.776 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -88.9 145.01 25.81 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.755 -177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.2 tp -145.59 108.54 4.54 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' A' ' 17' ' ' THR . 64.5 m-20 67.09 27.74 8.53 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.931 1.292 . . . . 0.0 112.215 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.63 13.26 48.1 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.217 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -139.75 141.47 36.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 122.579 -0.365 . . . . 0.0 110.292 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 25.1 p-10 -84.85 117.28 23.79 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -93.43 150.1 4.05 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.442 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.9 m -108.8 116.46 32.03 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 62.1 t -114.47 126.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -145.03 172.13 13.5 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.052 0.453 . . . . 0.0 111.674 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -83.47 119.85 25.18 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.441 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' A' ' 9' ' ' PHE . . . -98.12 -10.53 24.07 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 29.4 tt0 66.8 -69.02 0.13 Allowed 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.924 2.49 . . . . 0.0 112.193 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.2 p -155.09 -95.96 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.172 0.51 . . . . 0.0 112.084 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 . . . . . 0 C--N 1.29 -2.014 0 C-N-CA 124.459 1.104 . . . . 0.0 109.71 -177.432 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.982 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.9 mtp -74.62 -25.51 59.28 Favored 'General case' 0 C--O 1.212 -0.893 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.24 153.26 18.7 Favored 'General case' 0 C--O 1.257 1.472 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.91 6.97 47.1 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.973 0.796 . . . . 0.0 111.358 -175.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.8 t -62.77 119.74 7.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.122 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.49 142.91 27.29 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.201 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.21 120.85 40.2 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.001 0.905 . . . . 0.0 112.991 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -94.35 124.24 38.25 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.758 -177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.0 t -113.02 146.84 38.38 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -109.38 130.09 55.51 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.341 0.656 . . . . 0.0 109.563 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 79' ' ' VAL . 47.1 t -130.14 113.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -121.1 156.95 16.13 Favored Glycine 0 C--N 1.299 -1.488 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.08 6.89 Favored Glycine 0 C--N 1.312 -0.802 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 17' ' ' THR . 86.5 mt -78.23 162.66 26.4 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.243 -0.479 . . . . 0.0 110.22 -177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.08 -177.14 4.21 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-O 121.251 0.548 . . . . 0.0 111.161 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -76.72 -14.71 59.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.626 -175.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.43 -4.72 16.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 HG21 HD22 ' A' ' 13' ' ' LEU . 25.9 m -74.14 117.98 16.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.293 0.568 . . . . 0.0 111.108 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 51.2 p -106.99 171.69 7.23 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 35' ' ' SER . 1.6 p30 -70.76 -20.28 62.64 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -71.63 -52.5 17.65 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.515 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 4.1 m -60.7 -37.44 81.66 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.758 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.98 -48.23 82.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.6 -51.32 55.11 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.041 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 13.5 pt-20 -60.03 -40.67 90.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.179 0.49 . . . . 0.0 111.58 -176.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.21 79.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.256 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -77.04 -20.41 55.94 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.9 t -70.87 -13.47 62.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.738 0.415 . . . . 0.0 110.966 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.24 -14.34 58.5 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -114.1 -44.2 3.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.148 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -137.13 177.86 19.43 Favored Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.481 -1.343 . . . . 0.0 113.934 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 20.3 mt-10 -83.66 114.98 21.94 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 124.541 1.136 . . . . 0.0 109.083 -176.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.0 mm -91.84 122.8 43.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.236 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.0 mt -94.25 -35.42 12.46 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -166.03 152.96 9.73 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 114.829 -1.078 . . . . 0.0 108.234 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 21.4 p -154.63 120.36 5.16 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -138.43 141.73 39.53 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.1 mm -86.68 138.35 19.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 44.0 mm -89.52 125.01 42.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -80.95 154.11 27.15 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.829 0.824 . . . . 0.0 112.592 -175.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -98.44 107.94 20.51 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -71.24 -42.96 68.17 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.91 0.862 . . . . 0.0 108.934 -173.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.75 -37.51 68.6 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 113.107 -1.86 . . . . 0.0 113.355 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.1 p -118.74 -6.39 10.61 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 21.83 70.4 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.371 -0.919 . . . . 0.0 111.239 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.1 mtp-105 -108.66 -159.12 0.67 Allowed 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 123.315 0.646 . . . . 0.0 109.927 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.4 m -103.31 150.0 24.19 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 172.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -69.71 -16.65 63.37 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.549 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.6 8.4 54.62 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.882 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -149.57 166.49 29.08 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -157.27 178.35 33.68 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.38 147.1 46.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 t -128.18 133.28 67.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.7 m -114.54 134.53 54.96 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-O 120.99 0.424 . . . . 0.0 112.123 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 95.3 m-85 -122.3 159.11 28.09 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.43 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -84.53 -50.18 7.94 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.728 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.14 151.65 27.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' MET . 8.5 tm-20 -55.53 -51.77 65.95 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.137 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -59.03 -42.16 89.52 Favored 'General case' 0 C--O 1.2 -1.528 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.435 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.86 -33.52 75.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.349 0.595 . . . . 0.0 110.344 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 64' ' ' ILE . 25.2 ttp -69.37 -50.69 43.83 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -59.48 -46.09 89.8 Favored 'General case' 0 N--CA 1.429 -1.511 0 C-N-CA 125.611 1.564 . . . . 0.0 111.53 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -56.7 -32.91 65.93 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 121.629 0.728 . . . . 0.0 110.153 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.06 -28.28 29.67 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.955 -177.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 60' ' ' MET . 88.4 mt -70.26 -56.81 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.832 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.59 -20.87 63.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.44 -31.61 40.88 Favored Glycine 0 C--O 1.216 -0.992 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.106 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 19.6 mmt -105.97 -24.25 12.46 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -66.81 116.08 7.31 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.098 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.05 -20.21 28.98 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 120.237 -0.982 . . . . 0.0 113.418 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -88.22 172.98 9.06 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.203 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 13.4 t70 -99.06 134.56 41.73 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.1 125.35 23.17 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 57.27 25.79 11.54 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 125.619 1.568 . . . . 0.0 111.978 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.66 4.68 57.98 Favored Glycine 0 N--CA 1.418 -2.523 0 C-N-CA 120.156 -1.021 . . . . 0.0 113.573 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.771 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -139.77 143.67 37.04 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.778 1.289 . . . . 0.0 114.092 172.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.513 ' H ' ' HE ' ' A' ' 75' ' ' ARG . 4.4 p-10 -73.68 120.96 20.0 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 123.913 0.885 . . . . 0.0 110.828 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 pt -99.99 143.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.237 0 CA-C-N 114.541 -1.209 . . . . 0.0 112.211 -174.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.1 m -108.96 117.64 34.74 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 10' ' ' VAL . 47.8 t -119.58 133.37 66.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -155.27 172.77 17.63 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -79.42 150.28 31.36 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.8 -5.0 35.78 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.12 -170.27 0.19 Allowed 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.803 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.6 t 61.41 -151.06 0.39 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 C--N 1.296 -1.728 0 O-C-N 122.398 -0.189 . . . . 0.0 110.696 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -70.35 -26.88 63.95 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.54 166.26 16.38 Favored 'General case' 0 C--O 1.263 1.767 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 171.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 62.23 75.98 0.38 Allowed 'General case' 0 C--O 1.252 1.213 0 CA-C-O 122.933 1.349 . . . . 0.0 109.469 -175.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 93.8 t -122.87 146.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 CA-C-N 112.486 -2.143 . . . . 0.0 107.594 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' OE1' ' HB2' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -109.28 143.54 38.63 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 177.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -111.23 101.33 9.83 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-O 122.209 1.004 . . . . 0.0 111.444 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.476 ' HB2' ' OE1' ' A' ' 5' ' ' GLU . 15.1 tpp180 -84.34 123.72 30.49 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 113.417 -1.72 . . . . 0.0 108.149 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.7 t -108.25 138.32 44.74 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -101.93 121.06 41.42 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 HG13 HG22 ' A' ' 79' ' ' VAL . 39.7 t -121.26 113.23 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -122.97 156.35 17.36 Favored Glycine 0 C--N 1.294 -1.797 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' HD2' ' A' ' 75' ' ' ARG . . . 87.45 45.44 5.25 Favored Glycine 0 CA--C 1.494 -1.264 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD22 HG21 ' A' ' 17' ' ' THR . 88.3 mt -82.25 175.89 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.966 -0.617 . . . . 0.0 110.808 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.467 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -105.31 -170.56 1.77 Allowed 'General case' 0 N--CA 1.42 -1.941 0 CA-C-O 121.241 0.543 . . . . 0.0 111.147 -177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.9 p90 -78.52 -20.95 49.62 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.37 6.3 18.66 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.405 0.622 . . . . 0.0 110.731 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 HG21 HD22 ' A' ' 13' ' ' LEU . 14.1 m -69.14 118.27 11.83 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-O 121.904 0.859 . . . . 0.0 110.379 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.4 p -126.87 173.87 9.25 Favored 'General case' 0 CA--C 1.462 -2.412 0 CA-C-N 114.581 -1.191 . . . . 0.0 108.48 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -63.39 -32.65 74.14 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.808 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB2' ' OE2' ' A' ' 24' ' ' GLU . 1.9 pt20 -68.25 -53.32 25.43 Favored 'General case' 0 C--O 1.213 -0.834 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.81 176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -62.01 -27.83 69.15 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 111.907 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.435 HD22 HD13 ' A' ' 37' ' ' ILE . 24.8 tp -70.17 -56.26 7.28 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.57 -49.31 78.07 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 113.427 -176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.449 ' OE2' ' HB2' ' A' ' 20' ' ' GLN . 40.3 mt-10 -59.33 -40.59 86.78 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 123.355 0.662 . . . . 0.0 111.185 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.7 -44.37 74.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.711 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.422 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 95.4 m-85 -82.66 -13.05 57.14 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.3 t -68.58 -13.63 62.47 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -78.59 -15.8 58.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.769 176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -98.83 -44.11 6.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.007 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.17 -170.78 34.94 Favored Glycine 0 CA--C 1.495 -1.185 0 C-N-CA 117.444 -2.312 . . . . 0.0 114.632 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -64.22 118.81 9.14 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 124.816 1.246 . . . . 0.0 111.015 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.59 116.98 37.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.385 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.2 mt -90.08 -27.39 19.7 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -168.23 149.8 5.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.695 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.7 p -154.93 101.86 2.3 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -132.44 131.69 42.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.435 HD13 HD22 ' A' ' 22' ' ' LEU . 47.2 mm -76.92 140.33 17.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.3 mm -76.33 102.21 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -86.58 164.47 16.85 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.985 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -96.16 114.67 26.38 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -71.13 -30.57 66.66 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.241 0.544 . . . . 0.0 111.09 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -74.19 -43.91 55.42 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.509 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 43.2 p -115.23 -6.4 12.41 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.4 12.66 82.81 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.943 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -86.68 -177.66 6.18 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 111.498 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.5 m -103.12 138.84 39.41 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.8 mtt180 -92.74 21.76 5.3 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.76 -4.32 85.96 Favored Glycine 0 C--O 1.239 0.468 0 N-CA-C 115.218 0.847 . . . . 0.0 115.218 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -149.17 166.46 28.76 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.681 0.741 . . . . 0.0 110.148 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.23 174.44 35.44 Favored Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -123.94 142.09 51.46 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.094 0.473 . . . . 0.0 111.284 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.78 140.63 40.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -117.95 123.86 46.81 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 120.926 0.393 . . . . 0.0 111.538 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -115.57 169.84 8.88 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.166 177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -110.34 -19.74 12.87 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.97 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -104.47 147.93 27.02 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.289 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.572 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 41.1 tt0 -80.34 -35.28 35.74 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.79 -177.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HG3' ' OD2' ' A' ' 62' ' ' ASP . 26.4 tptp -69.19 -40.45 78.07 Favored 'General case' 0 C--O 1.2 -1.526 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.34 -39.29 69.84 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.666 0.604 . . . . 0.0 110.22 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.9 ttp -69.55 -38.59 77.52 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 33.8 mmt180 -62.67 -51.01 68.91 Favored 'General case' 0 C--O 1.201 -1.496 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.382 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' OD2' ' HG3' ' A' ' 58' ' ' LYS . 13.1 m-20 -59.92 -31.56 69.95 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.011 0.524 . . . . 0.0 111.184 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 67' ' ' MET . . . -66.86 -35.92 81.14 Favored 'General case' 0 C--O 1.213 -0.827 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.476 177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.441 HG12 HG12 ' A' ' 79' ' ' VAL . 91.0 mt -75.73 -55.14 12.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.353 177.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -56.97 -44.25 82.44 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.046 1.338 . . . . 0.0 112.364 -176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -93.02 -4.61 64.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.847 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.573 ' HB2' ' O ' ' A' ' 63' ' ' ALA . 18.4 mmt -120.62 -26.12 5.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -69.63 116.08 9.62 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.431 -176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.38 -5.96 31.77 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.673 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 26.0 pt20 -107.74 153.81 22.42 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.738 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 7.6 m-20 -80.38 95.55 6.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.843 0.83 . . . . 0.0 111.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -95.39 129.55 42.5 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 31.6 t70 61.84 24.75 14.78 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.519 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.07 -2.78 61.71 Favored Glycine 0 N--CA 1.435 -1.369 0 CA-C-N 115.066 -0.97 . . . . 0.0 114.469 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 12' ' ' GLY . 3.9 tmt_? -138.85 137.75 36.87 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.969 1.384 . . . . 0.0 111.236 178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 1.9 p30 -63.89 113.78 3.66 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.825 -1.079 . . . . 0.0 112.738 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -90.76 145.8 6.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.454 -1.248 . . . . 0.0 112.399 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -110.39 116.37 31.31 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.441 HG12 HG12 ' A' ' 64' ' ' ILE . 21.4 t -119.99 134.39 63.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -173.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.88 172.47 17.34 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 122.82 0.448 . . . . 0.0 109.876 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -84.13 133.95 34.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.543 0.687 . . . . 0.0 109.435 -177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.92 -16.16 25.51 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.228 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 85' ' ' ARG . 73.1 mm-40 -87.95 52.28 2.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 170.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 m -59.59 107.29 0.57 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.531 1.133 . . . . 0.0 111.471 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 83' ' ' GLN . 34.2 mtm180 . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.352 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.152 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt 175.96 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.2 86.16 2.4 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.477 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.43 95.05 10.06 Favored 'General case' 0 CA--C 1.484 -1.569 0 CA-C-O 122.543 1.163 . . . . 0.0 109.548 -176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.95 150.14 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.792 0 CA-C-N 112.776 -2.011 . . . . 0.0 106.482 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.85 120.64 1.34 Allowed 'General case' 0 C--O 1.253 1.261 0 O-C-N 125.136 1.523 . . . . 0.0 111.355 -177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.465 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 28.5 m-85 -96.18 113.08 24.65 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.171 0.986 . . . . 0.0 112.647 -174.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 83' ' ' GLN . 23.6 tpp180 -85.73 135.22 33.83 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.688 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.685 ' SG ' ' HG3' ' A' ' 60' ' ' MET . 56.0 m -112.69 146.66 38.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -109.61 120.57 42.91 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 38.2 t -126.14 114.2 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.3 157.93 14.83 Favored Glycine 0 C--N 1.297 -1.631 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.39 17.78 25.68 Favored Glycine 0 C--N 1.309 -0.931 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.414 HD22 HG21 ' A' ' 17' ' ' THR . 93.5 mt -78.08 162.78 26.43 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.034 0.445 . . . . 0.0 110.117 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.42 168.22 11.44 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 121.456 0.646 . . . . 0.0 111.584 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -71.69 -5.74 36.07 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.128 1.371 . . . . 0.0 110.445 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.2 1.59 10.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.016 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.414 HG21 HD22 ' A' ' 13' ' ' LEU . 97.6 m -69.28 118.81 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.113 0.482 . . . . 0.0 110.306 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -101.35 162.95 12.53 Favored 'General case' 0 CA--C 1.466 -2.253 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.014 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -63.02 -30.5 71.65 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.897 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.26 -57.71 6.17 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.089 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 30.4 p -62.4 -27.86 69.38 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.412 0.625 . . . . 0.0 112.31 -177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.502 HD22 HD13 ' A' ' 37' ' ' ILE . 34.6 tp -69.81 -47.7 61.82 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.29 -51.78 56.72 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.131 -0.941 . . . . 0.0 113.301 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 21' ' ' THR . 11.6 pt-20 -56.28 -43.27 78.64 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.945 0.373 . . . . 0.0 111.59 -177.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.36 -40.45 90.81 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.759 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 22' ' ' LEU . 77.7 m-85 -88.11 -22.05 24.34 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.7 p -67.98 -13.54 62.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.534 0.683 . . . . 0.0 111.344 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -72.7 -15.48 61.69 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.4 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -110.54 -44.5 3.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.353 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.54 -170.92 24.71 Favored Glycine 0 CA--C 1.496 -1.129 0 C-N-CA 118.579 -1.772 . . . . 0.0 113.406 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 1.4 pm0 -73.42 127.04 31.58 Favored 'General case' 0 N--CA 1.428 -1.529 0 C-N-CA 123.908 0.883 . . . . 0.0 111.194 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.0 mm -99.73 114.75 38.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 53' ' ' THR . 61.1 mt -81.91 -37.14 27.26 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.94 151.86 16.67 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 p -147.41 101.95 3.42 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -124.48 126.58 46.13 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.502 HD13 HD22 ' A' ' 22' ' ' LEU . 43.9 mm -76.4 141.53 15.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.64 89.62 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.973 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -87.61 149.56 24.23 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 113.739 -1.573 . . . . 0.0 110.679 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -74.36 148.83 40.93 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.72 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -72.82 -39.92 66.23 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 123.216 0.323 . . . . 0.0 111.335 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -84.23 -48.15 10.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.342 0.592 . . . . 0.0 111.185 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.4 p -88.13 -16.51 33.26 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.011 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.74 26.62 71.19 Favored Glycine 0 C--O 1.222 -0.633 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.928 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 73.0 mtt-85 -122.68 161.2 24.28 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -173.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m -59.35 119.52 7.59 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 125.684 1.593 . . . . 0.0 111.805 -176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mtp85 -86.36 29.16 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.05 -3.26 73.06 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 114.595 0.598 . . . . 0.0 114.595 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -158.75 170.55 21.88 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 118.051 0.926 . . . . 0.0 111.34 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.84 177.49 40.35 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' A' ' 7' ' ' ARG . 97.2 m-85 -128.17 147.95 50.58 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.992 0.425 . . . . 0.0 111.244 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 36.7 t -125.09 143.13 39.75 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 33' ' ' LEU . 87.5 m -118.54 128.55 54.67 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -114.08 169.19 9.19 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.231 1.013 . . . . 0.0 108.782 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HB2' HD11 ' A' ' 33' ' ' LEU . 23.7 ttmm -109.91 -28.73 8.6 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 176.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.75 144.21 31.78 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.459 0.647 . . . . 0.0 111.079 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 11.4 pt-20 -77.88 -32.06 51.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.535 -177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HG2' ' OD1' ' A' ' 62' ' ' ASP . 49.0 tttm -69.1 -53.66 19.08 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.76 64.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.251 0.969 . . . . 0.0 110.845 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.685 ' HG3' ' SG ' ' A' ' 8' ' ' CYS . 50.9 ttp -58.17 -44.4 87.97 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.709 175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.7 mtt85 -77.07 -35.66 56.5 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' OD1' ' HG2' ' A' ' 58' ' ' LYS . 4.7 m-20 -58.13 -31.43 67.18 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -76.9 -39.27 51.52 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.868 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 60' ' ' MET . 77.1 mt -69.74 -56.83 10.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.14 -18.2 65.2 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.51 -21.87 13.83 Favored Glycine 0 C--O 1.218 -0.848 0 C-N-CA 120.331 -0.938 . . . . 0.0 114.104 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 40.3 tpp -109.14 -24.96 10.89 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 117.684 0.742 . . . . 0.0 111.551 -176.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.19 116.55 8.92 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 122.131 -0.355 . . . . 0.0 110.297 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.31 -7.3 32.4 Favored Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.159 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -103.17 177.53 4.81 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.398 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -100.53 142.01 32.6 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.035 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.3 tp -138.51 131.02 28.97 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 56.99 27.64 13.55 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.871 0.869 . . . . 0.0 111.169 -177.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.78 23.55 64.14 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.928 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.62 146.68 48.15 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -89.44 120.8 31.09 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.414 ' CG2' HD23 ' A' ' 13' ' ' LEU . 36.0 pt -106.96 143.16 18.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.935 -1.029 . . . . 0.0 113.31 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -106.93 115.91 31.01 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.112 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.91 131.67 60.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -145.22 161.42 39.58 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.888 0.375 . . . . 0.0 111.292 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.57 120.73 21.38 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.815 -178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -102.66 -18.23 15.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.871 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' ARG . 77.7 mt-30 60.81 -164.93 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 123.834 0.709 . . . . 0.0 110.861 -174.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -73.47 95.35 2.22 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.96 -0.463 . . . . 0.0 112.117 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 C--O 1.246 0.914 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 176.027 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.845 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt -176.19 -54.61 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.03 116.3 11.87 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 104.177 -2.527 . . . . 0.0 104.177 176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.21 58.52 3.3 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.272 1.034 . . . . 0.0 109.465 -171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 70.5 t -137.65 130.33 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.37 150.72 40.31 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.583 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 42.9 m-85 -105.07 115.54 30.45 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 114.944 -1.025 . . . . 0.0 109.8 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -100.29 127.94 46.47 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-N 113.804 -1.544 . . . . 0.0 109.924 -172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.6 t -113.65 136.98 52.23 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -97.86 122.48 41.02 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.9 t -120.77 113.64 40.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.83 159.3 14.02 Favored Glycine 0 C--N 1.295 -1.696 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.62 27.55 12.76 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.68 171.46 14.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.131 0.491 . . . . 0.0 111.52 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.509 ' HB3' ' OD2' ' A' ' 73' ' ' ASP . . . -102.91 -167.33 1.37 Allowed 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.893 -176.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -78.59 -31.46 47.19 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.786 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -108.7 1.08 20.92 Favored 'General case' 0 C--O 1.256 1.396 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -170.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -62.21 117.85 6.61 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.55 158.43 18.56 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.853 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 35' ' ' SER . 21.3 p-10 -69.58 -35.51 75.4 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 122.804 0.442 . . . . 0.0 112.133 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.8 tp60 -61.67 -55.96 24.9 Favored 'General case' 0 N--CA 1.422 -1.865 0 O-C-N 123.725 0.641 . . . . 0.0 110.433 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.1 p -65.45 -27.97 68.89 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.7 tp -59.89 -33.66 72.14 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.39 -54.53 15.84 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.072 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.14 -40.22 70.34 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.652 0.381 . . . . 0.0 111.641 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.63 96.35 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.523 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -88.52 -10.21 49.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 -14.39 61.18 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.517 0.327 . . . . 0.0 110.62 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -63.67 -34.46 77.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.001 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.45 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 71.0 m-85 -92.99 -41.88 9.75 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.971 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -172.64 -161.81 23.71 Favored Glycine 0 N--CA 1.427 -1.923 0 C-N-CA 117.549 -2.262 . . . . 0.0 115.131 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 54' ' ' PHE . 29.5 mt-10 -68.1 117.97 10.64 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 125.066 1.346 . . . . 0.0 111.025 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.2 mm -97.74 110.83 26.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.0 mt -90.29 -26.15 20.16 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.567 ' OD1' ' HE3' ' A' ' 36' ' ' LYS . 9.1 t70 -168.92 152.32 5.23 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.659 -176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 19' ' ' ASP . 11.2 p -154.88 105.54 2.58 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.599 ' HE2' ' O ' ' A' ' 35' ' ' SER . 7.6 mmpt? -110.73 133.42 53.35 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -175.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 19' ' ' ASP . 38.4 mm -100.78 114.03 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.404 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 23.9 mm -83.07 115.62 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -177.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -107.55 165.62 11.28 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.191 -171.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -100.46 139.42 36.16 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.472 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -31.44 64.36 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 176.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -53.71 -56.98 12.56 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.923 -172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 49.6 p -115.33 -25.44 7.99 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 111.687 0.255 . . . . 0.0 111.687 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.37 20.99 15.95 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.507 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -106.52 -174.29 2.5 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.8 t -77.67 156.45 30.72 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 38' ' ' ILE . 19.2 mmm180 -76.49 -3.12 35.62 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.91 8.47 54.09 Favored Glycine 0 N--CA 1.424 -2.125 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.273 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -156.54 168.14 28.3 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.1 -179.36 33.87 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -127.47 138.49 52.96 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 122.325 0.25 . . . . 0.0 110.556 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.7 t -115.95 137.65 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.4 m -118.01 122.23 42.66 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 120.957 0.408 . . . . 0.0 111.904 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLU . 83.5 m-85 -114.16 163.79 14.74 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.039 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 31' ' ' GLU . 2.8 ttpm? -96.9 -33.4 11.63 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.199 176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -104.45 139.76 38.91 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.324 1.059 . . . . 0.0 112.192 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -52.69 -49.12 65.94 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 128.067 2.547 . . . . 0.0 112.251 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -78.64 -34.76 46.23 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 123.013 0.525 . . . . 0.0 110.473 -173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.56 -35.67 74.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.116 0.885 . . . . 0.0 108.952 173.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 6' ' ' TYR . 53.5 ttp -72.91 -43.53 62.32 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.247 175.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -59.69 -49.04 79.27 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 26.9 t70 -58.4 -31.12 67.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.422 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 67' ' ' MET . . . -72.21 -32.38 66.71 Favored 'General case' 0 C--O 1.214 -0.789 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.484 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 60' ' ' MET . 84.1 mt -75.58 -56.57 8.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -31.37 70.97 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.175 -0.92 . . . . 0.0 112.889 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.14 -4.64 56.45 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 115.226 0.85 . . . . 0.0 115.226 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.429 ' SD ' HD11 ' A' ' 77' ' ' ILE . 55.3 tpp -120.17 -23.25 6.33 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 118.104 0.952 . . . . 0.0 111.6 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.43 116.62 7.62 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 122.269 -0.269 . . . . 0.0 111.126 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.29 -9.8 31.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 120.078 -1.058 . . . . 0.0 113.613 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -101.51 175.69 5.48 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 76' ' ' ASN . 12.3 t70 -103.88 134.07 47.79 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -175.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.63 126.61 22.51 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.509 ' OD2' ' HB3' ' A' ' 14' ' ' ALA . 38.7 t70 62.35 25.09 14.97 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.861 1.265 . . . . 0.0 110.571 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.96 -1.06 62.89 Favored Glycine 0 N--CA 1.427 -1.957 0 C-N-CA 119.954 -1.117 . . . . 0.0 112.59 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.795 ' NE ' ' HA ' ' A' ' 75' ' ' ARG 0.336 1.1 mmp_? -128.34 145.03 51.19 Favored 'General case' 0 CA--C 1.476 -1.875 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 176.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 23.7 t-20 -85.19 115.01 22.73 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.762 -177.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 ' SD ' ' A' ' 67' ' ' MET . 30.0 pt -101.89 141.45 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.418 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.791 -169.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.6 m -105.05 115.65 30.63 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.025 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.58 125.2 66.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -140.48 172.62 12.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 120.901 0.382 . . . . 0.0 110.044 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -93.48 129.14 39.78 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.132 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.81 51.16 1.66 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.556 ' HG3' ' H ' ' A' ' 84' ' ' SER . 10.9 pt20 -44.11 -68.87 0.16 Allowed 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 126.366 1.866 . . . . 0.0 115.259 -175.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.556 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 16.9 m -87.54 87.71 7.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.609 0 C-N-CA 124.526 1.13 . . . . 0.0 110.441 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.332 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -56.29 127.89 33.11 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 122.975 0.51 . . . . 0.0 110.648 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.32 87.06 0.61 Allowed 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 55' ' ' LYS . 17.6 mm-40 -93.17 74.18 4.65 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 122.036 0.922 . . . . 0.0 110.395 -174.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.2 p -167.04 166.04 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.05 112.86 23.1 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 120.931 0.395 . . . . 0.0 110.815 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.6 ' CE2' ' HG2' ' A' ' 57' ' ' GLU . 11.8 m-85 -93.27 89.8 6.54 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.538 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 35.4 ttm105 -85.5 130.12 34.65 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.892 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.3 t -114.48 146.67 40.39 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 124.313 1.045 . . . . 0.0 108.512 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -100.48 128.51 46.52 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.446 0.698 . . . . 0.0 109.195 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.9 t -129.12 113.83 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.06 156.81 15.41 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.8 30.06 9.32 Favored Glycine 0 CA--C 1.503 -0.663 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 17' ' ' THR . 95.6 mt -77.87 169.92 17.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.394 0.616 . . . . 0.0 111.509 -176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB1' ' OD2' ' A' ' 73' ' ' ASP . . . -102.21 -178.31 3.66 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.584 -174.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 21.7 p-90 -77.97 -31.22 50.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.029 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.15 1.92 55.89 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.096 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 HG21 HD22 ' A' ' 13' ' ' LEU . 18.5 m -78.38 117.67 19.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 C-N-CA 119.812 -0.755 . . . . 0.0 109.71 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.483 ' H ' HG22 ' A' ' 21' ' ' THR . 19.3 p -119.65 165.0 15.04 Favored 'General case' 0 CA--C 1.472 -2.024 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.745 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -59.12 -32.4 69.8 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.247 -1.342 . . . . 0.0 111.479 -175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.403 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 14.5 mt-30 -65.99 -59.45 3.81 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.696 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 18' ' ' THR . 14.7 t -64.48 -27.68 69.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.126 -174.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD22 HD13 ' A' ' 37' ' ' ILE . 36.5 tp -60.8 -47.47 86.2 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.23 -42.21 67.03 Favored Glycine 0 N--CA 1.44 -1.065 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.66 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 39.6 mt-10 -56.91 -46.6 81.87 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.112 0.565 . . . . 0.0 110.881 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.95 94.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.038 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 79.0 m-85 -83.29 -13.16 55.75 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.9 t -61.66 -25.2 67.23 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.45 0.643 . . . . 0.0 109.901 177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -61.25 -31.95 71.75 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.379 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.39 -40.42 12.75 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.497 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.66 163.6 29.24 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.98 143.38 57.99 Favored 'General case' 0 C--O 1.261 1.71 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.76 144.55 10.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 112.871 -1.968 . . . . 0.0 110.628 -172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.4 mt -100.74 -43.56 6.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -153.57 150.5 28.74 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.7 p -148.61 105.76 3.62 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -126.5 127.3 45.14 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD13 HD22 ' A' ' 22' ' ' LEU . 43.5 mm -78.1 134.05 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 105.568 -2.012 . . . . 0.0 105.568 171.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 46.4 mm -74.26 110.17 7.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -103.01 153.68 20.0 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.285 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -74.63 142.29 44.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.717 ' NH2' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.18 -7.08 44.31 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 179.258 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.717 ' HB2' ' NH2' ' A' ' 41' ' ' ARG . 31.0 tt0 -86.7 -62.96 1.39 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.505 0.669 . . . . 0.0 110.88 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 p -121.05 -0.72 9.95 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.75 1.99 89.7 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.691 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -61.69 139.44 58.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.625 0.37 . . . . 0.0 110.347 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 p -63.61 144.82 56.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.231 0.538 . . . . 0.0 111.798 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 2.7 mmp_? -99.95 5.3 45.23 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 122.063 -0.398 . . . . 0.0 111.382 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.21 6.37 74.9 Favored Glycine 0 C--N 1.321 -0.304 0 C-N-CA 120.805 -0.712 . . . . 0.0 114.118 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -154.12 167.43 29.85 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 117.341 0.57 . . . . 0.0 109.782 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.62 175.6 39.01 Favored Glycine 0 N--CA 1.43 -1.766 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -118.63 140.18 50.31 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 120.774 0.321 . . . . 0.0 110.497 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.83 121.89 64.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 34.4 m -106.59 130.58 54.33 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.107 0.48 . . . . 0.0 111.993 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -111.42 161.53 16.01 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 124.279 1.032 . . . . 0.0 111.948 -177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 3' ' ' GLU . 24.2 tptp -100.26 -14.78 18.3 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.344 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -125.06 149.39 47.84 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.342 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' CE2' ' A' ' 6' ' ' TYR . 2.2 mm-40 -66.19 -39.93 90.07 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 123.728 0.811 . . . . 0.0 109.249 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -61.14 -48.1 83.19 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.17 -43.21 78.13 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.482 -176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 64' ' ' ILE . 51.3 ttp -72.47 -44.92 61.66 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.754 -178.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.484 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 86.0 mtt-85 -76.7 -37.56 55.89 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -64.84 -29.82 70.8 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.607 0.718 . . . . 0.0 109.181 177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 -32.17 71.07 Favored 'General case' 0 C--O 1.206 -1.19 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.521 176.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 60' ' ' MET . 97.3 mt -75.31 -56.39 8.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 61' ' ' ARG . 14.0 mm-40 -60.17 -36.9 78.62 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.38 -6.18 56.69 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.85 -1.167 . . . . 0.0 115.305 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 26' ' ' PHE . 10.7 tpt -121.22 -19.99 6.89 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.655 1.228 . . . . 0.0 111.537 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -73.39 119.54 17.77 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.216 -0.303 . . . . 0.0 111.284 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -2.37 54.24 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.753 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -104.17 -177.83 3.48 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 119.835 -0.746 . . . . 0.0 112.26 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 75' ' ' ARG . 14.7 t70 -95.26 144.68 25.65 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.933 -173.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.5 tp -143.92 106.85 4.48 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 169.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD2' ' HB1' ' A' ' 14' ' ' ALA . 32.1 t70 55.5 56.23 6.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.642 1.177 . . . . 0.0 111.723 -177.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.35 27.3 72.96 Favored Glycine 0 C--O 1.244 0.78 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.15 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -138.34 150.13 46.28 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.096 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -108.32 121.75 45.55 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.0 pt -102.61 140.79 20.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 31.7 m -105.34 122.21 45.48 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 47.9 t -123.05 124.97 71.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -155.07 171.72 19.3 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 3.4 mp0 -68.98 151.52 46.42 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 121.993 0.901 . . . . 0.0 112.121 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -127.08 22.97 6.58 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.617 ' HG3' ' H ' ' A' ' 84' ' ' SER . 7.8 tp-100 -148.59 -154.22 0.54 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.617 ' H ' ' HG3' ' A' ' 83' ' ' GLN . 6.5 m -46.79 114.22 0.8 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.895 1.278 . . . . 0.0 112.888 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.463 ' HG2' ' HB2' ' A' ' 81' ' ' GLU . 90.8 mtt180 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.206 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtm 73.33 80.82 0.13 Allowed 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.25 -62.61 0.42 Allowed 'General case' 0 CA--C 1.473 -2.005 0 C-N-CA 125.957 1.703 . . . . 0.0 111.678 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' O ' ' HB ' ' A' ' 4' ' ' VAL . 7.0 tp10 -94.16 159.26 15.22 Favored 'General case' 1 N--CA 1.369 -4.482 0 CA-C-N 113.118 -1.856 . . . . 0.0 106.905 -174.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 3' ' ' GLU . 75.4 t 83.41 109.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.368 0 C-N-CA 125.568 1.547 . . . . 0.0 111.201 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' CD ' ' HZ3' ' A' ' 55' ' ' LYS . 1.4 pm0 -63.89 156.12 28.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 112.765 -2.016 . . . . 0.0 115.403 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HE2' ' OE2' ' A' ' 57' ' ' GLU . 50.1 m-85 -126.8 156.11 41.78 Favored 'General case' 0 CA--C 1.485 -1.552 0 CA-C-N 114.322 -1.308 . . . . 0.0 109.858 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.8 ttp-105 -140.25 136.57 33.47 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.626 ' HG ' ' HE2' ' A' ' 54' ' ' PHE . 82.6 m -98.69 132.33 44.15 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-O 121.075 0.464 . . . . 0.0 110.058 -178.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -92.16 109.59 20.96 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.99 113.07 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.104 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -113.41 143.76 17.94 Favored Glycine 0 N--CA 1.422 -2.296 0 N-CA-C 110.839 -0.905 . . . . 0.0 110.839 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 91.57 48.08 3.31 Favored Glycine 0 N--CA 1.42 -2.377 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.9 mt -91.02 175.25 7.02 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.27 171.11 9.03 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -78.35 -17.65 56.23 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.806 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.0 -5.14 34.71 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.593 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.6 m -65.42 118.84 9.98 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 123.381 0.426 . . . . 0.0 110.115 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -100.82 160.34 14.45 Favored 'General case' 0 CA--C 1.48 -1.728 0 CA-C-O 122.005 0.907 . . . . 0.0 110.613 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -61.24 -31.25 71.04 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.277 -1.783 . . . . 0.0 111.2 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 24' ' ' GLU . 7.7 tt0 -68.51 -55.94 10.01 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.7 m -63.73 -27.93 69.54 Favored 'General case' 0 N--CA 1.409 -2.517 0 C-N-CA 124.354 1.062 . . . . 0.0 112.404 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.489 HD22 HD13 ' A' ' 37' ' ' ILE . 39.0 tp -63.2 -45.81 89.96 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.61 -44.76 81.08 Favored Glycine 0 N--CA 1.442 -0.949 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.658 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 20' ' ' GLN . 43.2 mt-10 -51.09 -47.7 61.84 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.147 0.979 . . . . 0.0 110.575 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.73 -42.77 99.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.422 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HD2' ' O ' ' A' ' 22' ' ' LEU . 97.0 m-85 -88.32 -10.46 49.39 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.9 m -65.46 -13.6 59.13 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.569 0.7 . . . . 0.0 111.262 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -77.93 -22.59 49.37 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.986 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HD1' ' OD2' ' A' ' 62' ' ' ASP . 63.0 m-85 -92.89 -44.6 8.38 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.481 -177.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 59' ' ' ALA . . . -166.9 -153.13 7.72 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.022 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -87.73 154.29 20.69 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 120.892 0.377 . . . . 0.0 111.604 -177.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.1 mm -116.83 115.86 50.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 mt -89.87 -30.87 17.61 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.42 0.629 . . . . 0.0 109.325 175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -157.01 145.0 19.29 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.844 -177.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 p -154.37 101.0 2.33 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -133.11 130.76 39.69 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.489 HD13 HD22 ' A' ' 22' ' ' LEU . 38.6 mm -79.28 134.48 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.687 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 171.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 45.7 mm -77.86 94.08 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.975 0 CA-C-O 121.873 0.844 . . . . 0.0 109.165 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -87.76 148.22 24.82 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.126 -1.397 . . . . 0.0 107.919 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.04 144.87 40.58 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.307 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.5 -47.04 51.76 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -75.29 -53.27 9.05 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.838 -170.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.508 ' OG1' ' HG2' ' A' ' 45' ' ' ARG . 35.4 p -92.28 -17.15 25.16 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.92 0.75 70.36 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 121.368 -0.444 . . . . 0.0 113.859 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.508 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 15.2 ptm180 -85.62 157.21 20.41 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 122.461 -0.435 . . . . 0.0 111.616 -176.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 m -61.89 132.31 52.6 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -94.96 4.36 53.89 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.19 4.27 58.59 Favored Glycine 0 C--N 1.322 -0.242 0 C-N-CA 120.114 -1.041 . . . . 0.0 115.354 171.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -152.2 166.52 31.46 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 117.924 0.862 . . . . 0.0 109.439 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -159.65 176.26 36.42 Favored Glycine 0 N--CA 1.436 -1.314 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 90.7 m-85 -126.83 149.5 49.67 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 122.662 0.385 . . . . 0.0 111.132 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' ARG . 40.0 t -134.2 118.12 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 176.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 34' ' ' ASP . 92.2 m -100.63 132.82 45.83 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 120.777 0.322 . . . . 0.0 111.567 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.626 ' HE2' ' HG ' ' A' ' 8' ' ' CYS . 89.2 m-85 -124.18 148.46 47.24 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' HZ3' ' CD ' ' A' ' 5' ' ' GLU . 8.4 tttm -93.24 -11.2 33.17 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.032 -1.067 . . . . 0.0 108.969 174.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 58' ' ' LYS . 5.4 t70 -102.91 137.79 40.65 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 122.316 1.055 . . . . 0.0 111.767 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' OE2' ' HE2' ' A' ' 6' ' ' TYR . 21.8 mt-10 -80.22 -26.34 39.17 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.228 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.513 ' HB3' ' OD2' ' A' ' 56' ' ' ASP . 11.2 tmtt? -64.49 -54.48 31.82 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . . . -48.68 -52.88 21.13 Favored 'General case' 0 C--O 1.21 -0.988 0 O-C-N 124.805 1.316 . . . . 0.0 111.841 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -63.24 -41.68 99.12 Favored 'General case' 0 C--O 1.213 -0.853 0 O-C-N 123.405 0.441 . . . . 0.0 111.997 -177.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -71.54 -43.95 65.47 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.467 0.651 . . . . 0.0 109.941 -175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.488 ' OD2' ' HD1' ' A' ' 29' ' ' PHE . 39.1 t70 -64.52 -30.65 71.67 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.724 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . -70.38 -49.95 43.8 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.444 176.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 68' ' ' ASN . 87.5 mt -58.31 -53.51 45.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.592 -178.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.45 -18.23 52.56 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.54 -38.6 8.13 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 120.81 -0.71 . . . . 0.0 114.038 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 24.6 mmt -103.53 3.51 34.82 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB2' ' O ' ' A' ' 64' ' ' ILE . 21.0 t-20 -73.22 116.39 13.71 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 12.83 48.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 119.264 -1.446 . . . . 0.0 114.33 174.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 76' ' ' ASN . 1.1 pp0? -104.24 159.01 16.06 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 118.104 0.952 . . . . 0.0 110.754 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -99.83 100.79 11.77 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.764 0.793 . . . . 0.0 112.161 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 tt -101.02 124.1 46.23 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 -178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 61.07 26.93 16.82 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.449 1.099 . . . . 0.0 111.044 -177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.35 22.2 59.17 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.164 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -138.0 132.59 32.48 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.14 0.495 . . . . 0.0 111.067 177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 70' ' ' GLN . 9.5 t-20 -79.36 118.38 21.21 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.752 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.6 pt -101.0 143.41 14.28 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.613 -173.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -109.42 117.13 33.21 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.05 132.83 56.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -153.11 169.33 23.21 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.609 0.764 . . . . 0.0 109.444 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 84' ' ' SER . 16.3 tp10 -78.83 133.53 37.02 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.474 0.654 . . . . 0.0 111.242 -176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.05 -16.34 41.02 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 123.651 0.78 . . . . 0.0 111.214 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.426 HE22 ' HB3' ' A' ' 7' ' ' ARG . 0.7 OUTLIER -85.21 -28.88 25.13 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.099 0.476 . . . . 0.0 111.023 174.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.502 ' H ' ' HG3' ' A' ' 81' ' ' GLU . 20.2 m -99.81 100.88 11.88 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -178.548 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.427 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.214 -1.14 0 CA-C-O 119.84 -0.422 . . . . 0.0 113.003 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.9 tpp -117.25 -66.08 1.12 Allowed 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 117.429 0.614 . . . . 0.0 110.777 -176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.49 -5.02 21.99 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.139 0.971 . . . . 0.0 109.866 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' CD ' ' H3 ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -122.59 72.85 1.09 Allowed 'General case' 0 N--CA 1.411 -2.418 0 CA-C-O 123.573 1.654 . . . . 0.0 107.23 -178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.1 t -84.18 156.59 3.64 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 CA-C-N 111.473 -2.603 . . . . 0.0 108.977 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 53' ' ' THR . 5.2 pt-20 -56.74 130.18 44.39 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -172.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -117.32 98.83 6.63 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-O 122.679 1.228 . . . . 0.0 109.447 169.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 52.8 ttm-85 -85.13 127.8 34.4 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 112.687 -2.052 . . . . 0.0 109.191 -174.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.7 t -110.89 147.11 35.3 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.904 0.882 . . . . 0.0 109.057 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -102.56 121.63 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -121.83 113.82 40.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 49' ' ' PHE . . . -115.62 160.17 13.43 Favored Glycine 0 N--CA 1.427 -1.905 0 N-CA-C 110.766 -0.933 . . . . 0.0 110.766 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.85 52.84 3.72 Favored Glycine 0 N--CA 1.435 -1.425 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 17' ' ' THR . 81.8 mt -89.05 166.92 13.56 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 120.873 0.368 . . . . 0.0 111.292 -178.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 75' ' ' ARG . . . -100.36 -158.04 0.65 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -169.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -78.33 -33.19 49.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.887 -169.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -125.12 18.18 8.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.718 0.77 . . . . 0.0 110.67 -174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 HG21 HD22 ' A' ' 13' ' ' LEU . 19.3 m -72.37 117.53 14.14 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.826 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.3 p -123.35 173.71 7.79 Favored 'General case' 0 CA--C 1.456 -2.66 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -59.63 -33.14 71.13 Favored 'General case' 0 C--N 1.283 -2.29 0 O-C-N 125.02 1.45 . . . . 0.0 110.316 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.4 -54.98 5.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.662 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 22.6 p -63.29 -27.51 69.38 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.5 tp -77.1 -37.36 54.49 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.42 -46.24 42.21 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.828 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 21' ' ' THR . 12.5 pt-20 -58.23 -39.45 79.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.864 0.466 . . . . 0.0 111.466 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.95 98.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.184 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -85.97 -13.48 47.51 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -72.51 -13.94 61.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.923 0.392 . . . . 0.0 110.661 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -82.42 -10.82 58.89 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.164 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.421 ' HD2' ' OD2' ' A' ' 62' ' ' ASP . 88.3 m-85 -104.71 -41.9 5.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.412 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 59' ' ' ALA . . . -157.45 165.11 33.3 Favored Glycine 0 N--CA 1.424 -2.101 0 C-N-CA 119.709 -1.234 . . . . 0.0 112.507 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -64.97 122.47 17.07 Favored 'General case' 0 C--O 1.251 1.146 0 O-C-N 124.154 0.561 . . . . 0.0 109.555 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.26 135.18 29.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.183 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.55 -39.63 10.75 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -162.6 156.99 21.4 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 p -147.66 105.8 3.75 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 15.2 mmmt -122.68 124.55 43.69 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.7 mm -77.3 137.76 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mm -79.78 110.26 15.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -80.88 156.95 25.81 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.045 0.926 . . . . 0.0 112.121 -177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 18.2 t70 -91.75 111.62 23.22 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.316 -176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' OE1' ' A' ' 42' ' ' GLU 0.406 0.5 OUTLIER -73.5 -7.89 53.67 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 177.405 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.652 ' OE1' ' HD2' ' A' ' 41' ' ' ARG . 1.6 mp0 -80.78 -57.07 3.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.866 0.365 . . . . 0.0 111.496 175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.3 p -110.35 -3.56 16.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.01 18.1 70.58 Favored Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.127 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -103.07 -151.58 0.43 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 18.7 m -106.19 147.71 28.74 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 20.3 mmm180 -78.86 -7.24 57.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 120.971 0.415 . . . . 0.0 110.878 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.6 6.63 57.28 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.094 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.419 ' CB ' ' HA2' ' A' ' 11' ' ' GLY . 28.2 p90 -151.44 164.55 36.51 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.21 174.65 37.82 Favored Glycine 0 N--CA 1.431 -1.67 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -114.12 138.12 50.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 120.813 0.339 . . . . 0.0 110.969 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 49.3 t -119.03 122.32 69.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 5' ' ' GLU . 35.9 m -101.07 121.2 41.38 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -99.78 152.16 20.43 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.221 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -74.42 -28.67 61.17 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.207 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.546 ' OD2' ' HB2' ' A' ' 58' ' ' LYS . 24.0 t70 -139.94 149.69 43.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.216 0.531 . . . . 0.0 111.294 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 61' ' ' ARG . 8.8 tm-20 -62.76 -34.42 77.19 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 125.48 1.512 . . . . 0.0 112.464 -179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HB2' ' OD2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -72.44 -38.47 68.29 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -66.88 -27.3 67.4 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.685 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 64' ' ' ILE . 52.2 ttp -75.15 -39.95 60.02 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.394 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 57' ' ' GLU . 27.4 mmt180 -54.17 -58.16 8.41 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.371 0.668 . . . . 0.0 111.957 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.421 ' OD2' ' HD2' ' A' ' 29' ' ' PHE . 23.8 t70 -58.43 -28.22 65.05 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.698 0.761 . . . . 0.0 110.789 -178.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.94 -37.61 47.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.856 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 60' ' ' MET . 75.1 mt -75.11 -56.68 8.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -64.53 -21.45 66.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.545 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -96.94 -41.97 3.41 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.289 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 83.3 mmm -92.95 -9.27 40.61 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -73.05 116.66 13.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 121.966 -0.459 . . . . 0.0 111.247 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.87 -25.32 17.05 Favored Glycine 0 N--CA 1.436 -1.347 0 C-N-CA 120.516 -0.85 . . . . 0.0 113.457 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -81.1 174.64 11.39 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.039 -0.664 . . . . 0.0 111.577 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -86.73 142.84 27.87 Favored 'General case' 0 C--O 1.254 1.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.636 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 60.6 tp -142.93 108.9 5.18 Favored 'General case' 0 N--CA 1.411 -2.386 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 34.3 t70 67.77 25.91 7.87 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 124.517 1.136 . . . . 0.0 111.34 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 96.91 15.69 38.49 Favored Glycine 0 C--O 1.259 1.687 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.502 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 1.2 tpp180 -139.97 141.42 36.42 Favored 'General case' 0 N--CA 1.439 -1.009 0 O-C-N 122.214 -0.58 . . . . 0.0 110.285 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -76.79 109.0 10.22 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -83.41 141.3 15.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.61 -176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 27.3 m -107.36 115.12 29.61 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.3 t -112.01 128.82 68.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -146.72 169.16 19.62 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.971 0.415 . . . . 0.0 110.548 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' A' ' 83' ' ' GLN . 28.8 tt0 -80.19 118.05 21.53 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.338 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ARG . . . -76.61 -8.21 56.77 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 121.011 0.434 . . . . 0.0 111.445 -177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.516 ' HB3' ' OE2' ' A' ' 81' ' ' GLU . 7.1 tt0 -72.43 -19.93 61.5 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.471 ' C ' ' HD2' ' A' ' 85' ' ' ARG . 19.8 m 69.29 64.31 0.28 Allowed 'General case' 0 C--O 1.245 0.863 0 C-N-CA 125.229 1.411 . . . . 0.0 114.201 176.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.471 ' HD2' ' C ' ' A' ' 84' ' ' SER . 3.5 mpt_? . . . . . 0 C--N 1.314 -0.961 0 C-N-CA 123.957 0.903 . . . . 0.0 108.919 169.424 . . . . . . . . 1 1 . 1 stop_ save_